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Complete sequencing and annotation of the M. leprae genome has provided new 
information related to proteins constituting its hypothetical proteome. Since M. leprae 
can not be grown in vitro, novel approaches are needed to determine which proteins are 
expressed during infection and whether these proteins are related to pathogenesis. 
Secreted proteins represent a distinct group of protein with respect to their structure and 
function, contribution to virulence and are of particular importance for vaccine 
development because they are often immunogenic and have the potential to be recognized 
early in infection. The objectives of this study were: 1) to identify putatively secreted 
proteins of M. leprae based on protein sequences homologies with known MT secreted 
proteins; 2) to apply bioinformatic tools designed to assess proteins for secretion, to 
proteins selected in objective 1 with the goal of improving the likelihood that selected 
proteins are secreted by M. leprae, 3) to validate secretion of selected ML proteins 
through genetic cloning of predicted secreted ML protein genes using surrogate host 
bacteria, E. coli and M. smegmatis. 
Bioinformatics identified 24 proteins with high probability for secretion in M. 
leprae. Fifteen of 24 ML genes showed more than 50% amino acid homology with their 
M. tuberculosis counterparts and were studied for gene expression and secretion.  mRNA 
analysis identified transcripts for all Sec-dependent pathway proteins of 15 genes 
predicted to be secreted in M. leprae. PhoA fusion studies in E. coli showed that 5 of 6 
(83%) ML proteins (ML0091, ML0097, ML0620, ML1811 and ML1812) were secreted 
in E. coli and  2 of 7 (29%) proteins (ML0715 and ML2569) were secreted in M. 
smegmatis. Only lipoproteins were secreted in M. smegmatis suggesting the importance 
 vii
of mycobacterial-related characteristics for secretion of ML lipoproteins. These results 
suggest that bioinformatic tools are reliable predictors for identifying secreted proteins in 




 Secreted proteins represent a distinct group of proteins with respect to their 
structure and function and contribution to virulence. They are of particular importance for 
vaccine development because they are often immunogenic and have the potential to be 
recognized early in infection. Little is known regarding mycobacterial protein secretion. 
Elucidation of protein secretion in M. leprae could provide new insights into virulence 
factors of M. leprae and provide a source of proteins with potential for vaccine 
development.  
A requisite step in protein secretion is protein translocation across the cytoplasmic 
membrane. This step is common to proteins that are released to the extracellular space or 
remain associated with the cell wall. The Sec-dependent pathway translocates precursor 
proteins containing N-terminal signal sequences across the cytoplasmic membrane 
(Oliver and Beckwith, 1981). Four different experimental approaches have been used to 
study M. tuberculosis secreted proteins. One is the analysis of culture filtrates that 
contains as many as 200 proteins (Sonnenberg and Belisle, 1997). This procedure has 
been used to study cultivable mycobacteria, such as M. tuberculosis and M. bovis, 
however, it cannot be applied to M. leprae since the bacteria must be harvested from 
infected host tissues where secreted proteins are lost during isolation of the bacilli.  
A second approach, comparative genomics, can be used to study secretion in M. 
leprae by identifying gene sequences for M. tuberculosis or other mycobacteria secreted 
proteins and using these proteins to identify homologs in the M. leprae genome. A third 
approach for studying secretion utilizes bioinformatics tools which consists of computer 
algorithms capable of predicting various properties of proteins. Location (e.g., 
cytoplasmic, cell membrane, secreted) of proteins have been predicted accurately using 
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this approach (Wiker et al, 2000).  While comparative genomics and bioinformatics are 
powerful analytical tools, results must be authenticated in biological systems. Genetic 
approaches have been used for authentication of secretion by making gene fusions with 
reporter genes encoding enzymes that become active upon translocation across the cell 
membrane (e.g. alkaline phosphatase, Hoffman and Wright, 1985). 
The following chapters describe studies designed to characterize secreted proteins 
in M. leprae using comparative genomics, bioinformatics (Chapter 2) and authentication 
of secretion by phoA-ML gene fusions (Chapter 3).  
Chapter 2 reports the use of a computer strategy to predict M.leprae secreted 
proteins taking advantage of the recently released M. leprae genome (Cole et al, 2001). 
Two different programs were used to identify proteins having secretory signal peptides 
but lacking additional membrane attachment domains: SignalP was used to predict the 
presence and location of signal peptide cleavage sites in amino acid sequences and 
Transmembrane Hidden Markov Model (TMHMM) was used to predict the location and 
orientation of transmembrane helices in protein sequences. 
Chapter 3 describes the results from gene transcription studies of 15 ML proteins 
predicted to be secreted using SignalP and TMHMM. The mRNA was purified from ML 
grown in nude mice and gene expression was monitored by RT-PCR. Each gene was 
cloned into 2 separate reporter plasmids in an attempt to demonstrate protein secretion in 
either E. coli or M. smegmatis.  
The hypothesis of this study is “M. leprae produces secreted proteins and 
SignalP/TMHMM are reliable bioinformatics tools to identify secreted proteins with 
special Sec-dependent characteristics. 
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The results of this work should help improve the understanding of Sec-dependent 
secretion in M. leprae and provides a listing of ML proteins with potential for 
development as vaccines or as diagnostic reagents capable of adding to current strategies 





Gerhard Hansen was the first to recognize that leprosy was caused by a bacterium, 
M. leprae, and in so doing identified the first human bacterial pathogen (Hansen, 1874). 
In 1960, Shepard described the limited multiplication of M. leprae which occurs when M. 
leprae are injected into the footpads of immunocompetent mice. This model made it 
possible for the first time to screen drugs for anti-leprosy activity, diagnose drug-resistant 
leprosy and study certain aspects of immunity to M. leprae, including evaluation of 
leprosy vaccines. Although M. leprae has not been cultured in routine laboratory media, 
in the late 1960s armadillos, nude mice, and immunosuppressed rats were shown to yield 
high numbers of M. leprae following infection. This has greatly increased the availability 
of M. leprae and permitted investigations into the genetics of M. leprae and the 
pathogenesis of leprosy. 
1.1.1. Epidemiology 
One-hundred three countries reported new leprosy cases for 2003 totalling 
524,000 globally. The global leprosy prevalence for 2002 was 612,000 (WHO). The 
global prevalence of leprosy has been significantly reduced from the estimated 10-15 
million cases reported a decade ago as a result of the World Health Organization program 
for global elimination of leprosy as a public health problem, based on the worldwide 
implementation of multidrug therapy (MDT). The implementation of MDT had a 
significant effect on reducing  the prevalence of leprosy, but the incidence of the disease 
has remained steady for the last 10-15 years at a rate of around 500,000-600,000 new 
cases per year. These data suggest that to truly eradicate leprosy other forms of 
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intervention such as tools for early diagnosis and prevention by vaccination may be 
necessary. 
Physical deformities in leprosy, which are permanent and often progressive, result 
in both reduced opportunities for patients and, in areas where leprosy is highly endemic, 
economic loss to the community. The consequences of leprosy related deformities and 
disabilities are much more pronounced than other disabilities due to the added effects of 
social disability resulting from the stigma attached to the disease. 
Unlike many other communicable diseases, there is considerable difficulty in 
identifying the three reference points that are involved in the transmission of leprosy. The 
identification of the point of onset of infection is the most important and difficult of the 
problems in the study of transmission. The human being is the only known reservoir of 
infection in leprosy, with the exception that naturally occurring disease with organisms 
indistinguishable from M. leprae has also been detected among wild armadillos in parts 
of the southern United States and Brazil. Up to 5% of armadillos in Louisiana have been 
found to have clinical disease, with about 20% having serological evidence of M. leprae 
infection (Truman et al, 1986). In addition, primates (Meyers et al, 1991) and 
chimpanzees (Leininger et al, 1980) naturally infected with M. leprae have been 
identified. 
1.1.2. Clinical Disease 
Clinical disease is categorized into two polar forms, tuberculoid (TT) and 
lepromatous (LL) leprosy and variations between the two polar forms are referred to as 
borderline leprosy.  
TT exhibits one or a few circumscribed skin lesions containing rare demonstrable bacilli. 
Aspects of cellular immunity appear to be active in the pathogenesis of TT leprosy as the 
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characteristic histological picture is one of well formed granulomas. LL is the 
disseminated form of the disease and the patient lacks demonstrable cell-mediated 
immunity (CMI) against M. leprae, resulting in disseminated growth of the bacilli. Nerve 
involvement in early LL is less severe than TT disease due in part to lack of CMI, but as 
the disease progresses, deformities may occur resulting from nerve invasion by massive 
numbers of bacilli. The majority of leprosy cases fall into the borderline classification. 
The major divisions of borderline disease are borderline tuberculoid (BT) and borderline 
lepromatous (BL). The gross appearance of leprosy along the disease spectrum from BT 
to BL generally reflects more numerous and disseminated lesions. The bacteria within 
lesions become more abundant and histopathological evidence of CMI diminishes as the 
clinical spectrum moves from BT to BL. Because borderline patients have significant 
levels of bacilli in their tissues and an active, although limited, immunological capacity to 
recognize M. leprae, they suffer from the greatest degree of nerve damage and related 
deformities (Gillis and Krahenbuhl, 1998). 
The natural course of leprosy often involves complications referred to as leprosy 
reactions. Reactions occur due to invasion of tissue by M. leprae and resultant 
immunological activity. The term reaction is used to describe the appearance of 
symptoms and signs of acute inflammation in lesions of patients with leprosy.  
There are two types of reactions: 
- Type 1, associated with cell-mediated hypersensitivity, occurs in patients with 
tuberculoid and borderline leprosy. Untreated, type 1 reactions may last for months or 
years, and can relapse unexpectadely. Neuritis is the most important consequence of a 
type 1 reaction and it may occur together with skin changes or independently, possibly 
reflecting hypersensitivity to different antigens of M. leprae. 
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- Type 2 reactions are thought to be associated with immune complexes and are 
also known as erythema nodosum leprosum (ENL). Type 2 reactions occur in patients 
with multibacillary disease and cause acute inflammation in any organ or tissue where M. 
leprae are found. ENL is seen primarily in BL and LL patients who produce large 
amounts of antibody to M. leprae (Hastings, 1994). 
1.1.3. Immunology 
In TT leprosy a strong cellular immune response to M. leprae is associated with 
limited disease and few, if any, demonstrable bacilli within granulomas located in the 
dermis and peripheral nerves. By contrast, in LL leprosy the absence of a cellular 
immune response leads to the uncontrolled proliferation of leprosy bacilli, extensive 
clinical lesions and a strong antibody response to mycobacterial antigens. In the 
borderline forms of leprosy progressive reduction in the cellular immune response and 
delayed- type hypersensitivity to M. leprae from BT to BL disease is accompanied by 
more frequent skin and nerve lesions, a greater bacillary load and increasing antibody 
levels (Waters, 1992). 
Activation of the cellular immune response to M. leprae is dependent on the 
initial interaction of T cells and antigen presenting cells (APC). Immunohistochemical 
studies have established the predominance of CD4+ over CD8+ T cells in lesions of TT 
leprosy patients at a ratio 2:1, while in BL/LL lesions there are far fewer lymphocytes 
and similar proportions (1:1) of CD4+ and CD8+ T cells (Mehra and Modlin, 1989).  
In tuberculoid leprosy, the granuloma is organized in distinct immunological 
microenviroments. The core of the granuloma is composed of well-differentiated 
macrophages and epithelioid cells diffusely infiltrated with CD4+ T lymphocytes. The 
predominant localization of CD8+T cells at the periphery of the granulomas suggests a 
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role in localizing the granulomatous reaction (Hastings, 1994). By contrast, the 
granuloma of lepromatous leprosy does not show this compartmentalization of CD4 and 
CD8 lymphocytes. CD4 and CD8 cells are distributed evenly throughout the granuloma 
and at an equal ratio. This arrangement of CD4 and CD8 T cells may reflect a relatively 
inefficient host response, allowing virtually uninhibited bacillary proliferation. The lack 
of a surrounding mantle of CD8 T cells may also facilitate the dissemination of the 
granulomatous response. 
One study of cytokine mRNA production in leprosy lesions using reverse 
transcriptase polymerase chain reaction (RT PCR) demonstrated a predominance of IL-2 
and IFN-γ transcripts in TT lesions, while IL-4, IL-5 and IL-10 were more apparent in LL 
lesions (Yamamura et al, 1991). These results are in agreement with the Th1/Th2 
paradigm of Mosmann and Coffman, 1989, and help explain the immunological spectrum 
underlying clinical leprosy. In addition, Th1 cells play a central part in the activation of 
cellular immune mechanisms whereas Th2 cells are of crucial importance for humoral 
immunity.  
Cells of the monocyte/macrophage lineage play various roles in the parasite/host 
relationship in leprosy, serving as cellular habitat for M. leprae, activators of T cells as 
antigen-presenting cells (APC), and effector cells in destruction of the bacillus. Other  
cells such as dendritic cells, Langerhans cells, B cells and endothelial cells can act as 
APC, but macrophages are uniquely efficient because they are capable not only of 
endocytosis of soluble  antigens, but they can also phagocytose particulate antigens and 
present them for stimulation of CMI in a major histocompatibility complex (MHC) class 
II restricted context. By secretion of T cell amplifying cytokines such as IL-1 and tumor 
necrosis factor alpha (TNFα), macrophages can up-regulate CMI. 
The immunological understanding of clinical leprosy continues to be dominated 
by the unusual specific anergy to M. leprae in LL. This minority of leprosy patients are 
unable to mount and efficient CMI to M. leprae. It is not known whether this specific 
immunodeficiency is predetermined, e.g., by genetic factors, by the kind and extent of 
exposure to other mycobacteria prior to infection with M. leprae, or is induced by M. 
leprae itself (Hastings, 1994). Based on the current understanding of the immunological 
events observed in leprosy a vaccine capable of inducing a Th1-type response to M. 
leprae in tissues may be capable of preventing the initial infection in TT and borderline 
leprosy, but may not in LL disease. 
1.2. Potential Significance of ML Secreted Proteins 
 Proteins released by mycobacteria to the extracellular environment have been the 
focus of research directed at identifying antigens that induce protective immunity and that 
may be involved in pathogenesis. Living mycobacteria are significantly more effective as 
inducers of protective immunity than dead bacilli (Bloch and Segal, 1955) and several 
studies have shown that the majority of bacterial virulence factors are extracellular 
proteins (Finlay and Falkow, 1997, and Miller and Cossart, 1999).. These observations 
underscore the importance of understanding secretion in M. leprae with the intent of 
identifying secreted proteins with potential for vaccine development and that may play a 
role in the pathogenesis of leprosy. 
Secreted proteins of M. tuberculosis are believed to be responsible in part for the 
efficacy of the live vaccine, M. bovis BCG, used against tuberculosis and leprosy. 
Shepard tried different mycobacterial preparations to measure protection in mice when 
challenged with M. leprae. The protection provided by BCG was markedly reduced when 
the vaccine was heated at 60ºC for 30 minutes killing the bacteria (Shepard et al, 1978). 
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A study in Malawi showed that a second BCG vaccination reduced the risk of leprosy by 
about 50% among individuals who had received BCG vaccination in the past. There was 
no evidence that addition of killed M. leprae enhanced the protection against leprosy 
afforded by BCG alone (Fine, 1996) suggesting that addition of static structural antigenic 
components of M. leprae did not improve the vaccine potency.  
Recognition of mycobacterial secreted proteins by the immune system may lead 
to early detection of infected macrophages and control of the disease. Subunit vaccines 
based on mixtures of culture filtrate proteins from M. tuberculosis have resulted in 
protective immunity in several studies using animal models of tuberculosis (Andersen P, 
1994; Hubbard et al, 1992; Pal and Horwitz, 1992; Roberts et al, 1995). Only a few of 
these proteins, for example, Ag85 complex and ESAT-6, have been isolated and 
characterized at present. Since M. leprae encodes homologs of these and other M. 
tuberculosis secreted proteins, the M. leprae secreted proteins represent an unexplored 
resource with great potential for developing new vaccines with therapeutic and 
prophylactic potential. 
1.3. Protein Secretion Mechanisms in Bacteria 
While exported proteins are those proteins primarily associated with the cell wall 
and possibly released into the culture medium over time, secreted proteins are soluble 
proteins that are released into the culture supernatant and not associated with the bacteria 
(Wiker et al, 1999). Prokaryotes have a number of pathways dedicated to the process of 
protein secretion. In general, these organisms translocate the majority of their secreted 
proteins via the Sec pathway. There are at least 6 different  pathways for protein secretion 
known in Gram-negative bacteria as reviewed by Thanassi and Hultgren, 2000. Four of 
these pathways release proteins with cleavable amino-terminal signal sequences to the 
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extracellular space in a two-step process that requires the Sec pathway for translocation 
across the inner membrane. The four pathways are autotransporters, chaperone/usher, 
type II and type IV secretion. The other pathways are Sec-independent and capable of 
exporting substrates in one step to the extracellular space.  These pathways are type I and 
type III secretion. An alternate secretion mechanism, the twin-arginine translocation (Tat) 
pathway, was originally identified in chloroplasts and has recently been found in bacteria 
and Archae (Santini et al, 1998). Tat signal peptides are similar to Sec signal peptides, 
but they contain a highly conserved twin-arginine motif. Mycobacterium species possess 
the genes required to translocate proteins by both the Sec and twin-arginine pathways. 
Various approaches have been used to study secretion and secreted proteins from 
bacteria.  Analysis of in vitro culture filtrates showed that M. tuberculosis produces as 
many as 200 putatively secreted proteins (Sonnenberg and Belisle, 1997).  Whereas this 
approach has been used successfully for cultivable bacteria, it is inappropriate for similar 
studies with the leprosy bacillus since M. leprae must be harvested from infected tissues 
resulting in the loss of secreted proteins from the purified bacilli.   
A second approach for studying secreted proteins utilizes comparative genomics 
and is readily applicable to studying M. leprae secreted proteins.  For example, genes 
known to encode secreted proteins in M. tuberculosis can be used to search the genome 
of M. leprae for sequences with strong DNA sequence similarities.  If these regions of 
similarity appear to encode genes with potential for secretion, then the M. leprae genes 
can be cloned and studied further to verify transcription, translation and secretion. 
Bioinformatics can also be used to support comparative genomic studies by 
providing tools for predicting properties of proteins, including cellular location.  
Computer algorithms have been developed that predict whether a protein is located 
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within the cytoplasm, the cell membrane or exported from the cell.  Proteins predicted for 
secretion by either comparative genomics or bioinformatics approaches require validation 
in biological systems.  Genetic tools can help bridge the gap between in silico predictors 
and in situ authentication.  A particularly useful genetic tool for this purpose utilizes gene 
fusion technology in which an unknown gene, suspected of being secreted, is fused to a 
reporter gene (e.g., alkaline phosphatase) which acts to signal the secretion event upon 
translocation.  For mycobacterial genes, including M. leprae, validation of secretion can 
be accomplished by cloning M. leprae-reporter fusion genes into E. coli or M. smegmatis. 
1.3.1. Signal Sequence Dependent Mechanisms for Translocation 
 
- Sec Pathway 
The Sec pathway translocates precursor proteins containing N-terminal signal 
sequences across the cytoplasmic membrane. The work of Oliver and Beckwith, 1981, 
established that the translocation of precursor proteins across the cytoplasmic membrane 
of E. coli requires the products of at least six genes. These genes, secA, secB, secD, secE, 
secF, and secY, encode interacting core-components of a complex translocation apparatus 
that consists of soluble and membrane integrated proteins. SecA is an ATPase that 
performs a central role in bacterial protein secretion, as it is the molecular motor that 
drives translocation. During the last few years, genes encoding SecA homologs from 
many different Gram-positive organisms, have been cloned (Klein et al, 1995; Blanco et 
al, 1996; Braunstein et al, 2001; Limia et al, 2001). The SecA protein binds the SecYEG 
complex to form the translocase, which mediates the ATP translocation of precursor 
proteins across the membrane. Proteins are secreted through an aqueous channel formed 
by the SecY, SecE and SecG polypeptides. SecY is the largest subunit of the membrane 
domain of the protein translocase. SecE is a small integral membrane protein that is 
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essential for translocation and viability. SecE of Gram-positive bacteria are considerably 
smaller than the E. coli SecE. Gram-positive SecE sequence is homologous to the 
carboxy-terminal part of the E.coli SecE, which corresponds to the highly conserved 
cytosolic loop region and the third transmembrane segment. Another protein, band 1 or 
SecG, copurifies and coimmunoprecipitates with SecY and SecE forming a three-
component complex as described by Brundage, et al, 1990. Sequence analysis showed 
that Gram-positive SecG have weak but significant sequence similarity with the E. coli 
SecG. SecG proteins from Gram-positive bacteria tend to be shorter than their Gram-
negative counterparts. Unlike SecY and SecE, SecG is not essential for viability and 
protein translocation in E. coli. SecD and SecF are needed for the late stages of 
translocation. SecB is a chaperone protein that forms a complex with precursor proteins 
but does not catalyze folding or unfolding.  SecB binds to the carboxy-terminus of Sec-A 
and is essential only in rapidly growing cells. This region of SecA is highly conserved 
among many Gram-negative and Gram-positive bacteria; however, no homologs with 
sequence similarity to SecB are present in any of the Gram-positive organisms of which 
the genome sequence has been completed. (van Wely et al, 2001). 
- Twin Arginine Translocation Pathway 
The twin-arginine (Tat) pathway translocates redox proteins across the 
cytoplasmic membrane in E. coli (Sargent, et al., 1998) and has recently been shown to 
secrete virulence factors from Psuedomonas aeruginosa (Dilks, et al., 2003). Even 
though secreted peptides exhibit a highly conserved twin-arginine motif, the Tat pathway 
is not universally conserved.  Signal sequences for proteins in the twin-arginine pathway 
are longer than those found in proteins secreted by Sec-dependent mechanisms and 
 13
 14
contain two arginines.  The twin arginine pathway differs from the Sec pathway in that 
proteins are secreted in a folded conformation. 
The Tat pathway is Sec-independent as multiple Sec factors have been shown to 
play no role in the process.  The E. coli Tat pathway contains 4 genes (tatA, tatB, tatC 
and tatD) organized in an operon with an unassociated fifth gene, tatE.  Tat B and C have 
essential roles in translocation, disruption of these genes leads to a complete block in the 
export of a subset of periplasmic proteins (Sargent, et al, 1998).  Disruption of tatD, 
however, has no detectable effect on secretion suggesting TatD is not involved in the 
export process.  The Tat complex has been purified from E. coli and was shown to 
contain only TatA, TatB and TatC (Bolhuis, et al, 2001). 
1.3.2. Amino-terminal Signal Peptides 
Signal peptides consist of short amino acid sequences which, after protein 
delivery to the correct subcellular compartment, are frequently removed by specialized 
signal peptidases. Three distinct domains of signal peptides can be recognized: The first 
domain is the amino-terminal N-domain containing positively charged residues (e.g., 
arginine or lysine). The positively charged N-domain is thought to interact with the 
translocation machinery and negatively charged phospholipids in the lipid bilayer of the 
cytoplasmic membrane during translocation. The second domain is the H-domain which 
is composed of hydrophobic residues that appear to adopt an α-helical conformation in 
the membrane. Helix-breaking glycine or proline residues are frequently present in the 
middle of this hydrophobic core. Helix-breaking residues found at the end of the H-
domain are thought to facilitate cleavage by a specific signal peptidase. The C-domain, 
following the H-domain, contains the cleavage site for signal peptidase. The (-3, -1) rule 
states that the residues at positions -3 and -1 (relative to the cleavage site) must be small 
and neutral for cleavage to occur correctly; this area is often referred to as an Ala-X-Ala 
cleavage site.  Alternatively, the C-domain may contain Gly or Ser in position -1 and Val, 
Ser or Thr in position -3 (von Heijne, 1983). 
The signal peptidase removes the signal peptide from the mature part of the 
secreted protein during or shortly after translocation. The mature part of the protein is 
released from the membrane and can fold into its native conformation. Finally the signal 
peptide is degraded by signal peptide peptidases and removed from the membrane 
(Tjalsma et al, 2000).  
Four major classes of amino-terminal signal peptides can be distinguished in B. 
subtilis on the basis of the signal peptidase recognition sequence. The first class is 
composed of typical signal peptides which are present in preproteins that are cleaved by 
one of the various type I signal peptidases. Although most proteins having such a signal 
seem to be secreted into the extracellular environment, some of them are retained in the 
cell wall. A subgroup of these signal peptides contain a so called twin-arginine motif 
(RR-motif), which directs proteins into a distinct translocation pathway known as the Tat 
pathway. The second major class of signal peptides is present in prelipoproteins, which 
are cleaved by the lipoprotein-specific type II signal peptidase. Lipoproteins have a well-
conserved lipobox that contains a cysteine residue that is lipid modified by the 
diacylglyceryl transferase prior to cleavage by signal peptidase II. After translocation 
across the cytoplasmic membrane, exported lipid-modified proteins remain anchored to 
the membrane by their amino-terminal lipid-modified cysteine residue. The third major 
class is formed by signal peptides of prepilin-like proteins which in B. subtilis, are 
cleaved by the prepilin-specific signal peptidase ComC. The recognition sequence for the 
prepilin signal peptidase is localized between the N- and H-domains, leaving the H-
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domain attached to the mature pilin after cleavage. Finally, the fourth major class of 
signal peptides is found on ribosomally synthesized bacteriocins and pheromones that are 
exported by ABC transporters. These signal peptides lack a hydrophobic H-domain and 
are removed from the mature protein by a subunit of the ABC transporter that is 
responsible for the export of a particular bacteriocin or pheromone (Tjalsma et al, 2000).  
1.3.3.Autotransporters 
The autotransporter secretion pathway is a terminal branch of the Sec pathway 
that exports proteins with diverse functions, including proteases, toxins, adhesins and 
invasins. A typical autotransporter contains three domains as described by Henderson et 
al, 1998: an amino-terminal signal sequence for secretion across the inner membrane by 
the Sec pathway, an internal passenger or functional domain, and a carboxy-terminal β-
domain. The β-domain inserts into the outer membrane to form what is predicted to be a 
β-barrel pore structure, similar to the bacterial porins, through which the passenger 
domain passes to the cell surface. A linker region connecting the passenger and β-
domains is also essential for export and may guide the passenger region through the β-
domain channel. Once secreted, the passenger domain is either retained on the bacterial 
surface or released into the environment by proteolysis. 
Neisseria secretes IgA protease, an enzyme that cleaves antibodies on mucosal 
surfaces by the autotransporter secretion pathway. IgA protease is synthesized as a pre-
proenzyme with an N-terminal signal peptide that initiates the precursor into the Sec 
pathway. After cleavage of the signal peptide by signal peptidase, the proenzyme resides 
in the bacterial periplasm. The C-terminal β-domain of IgA protease assumes a β-barrel 
structure that inserts into the outer membrane and functions as an autotransporter for the 
N-terminal domain. Once the N-terminal protease domain is exposed on the bacterial 
surface, it cleaves the proenzyme at the junction between the N-terminal and the C-
terminal domain. The cleaved N-terminal domain of the proenzyme is released from the 
bacterial surface and acts as  virulence factor. 
1.3.4. Chaperone/usher Pathway 
The chaperone/usher pathway is a branch of the Sec pathway for secretion of a 
broad range of adhesive virulence structures on the Gram-negative bacterial surface 
(Thanassi et al, 1998). Secretion across the outer membrane by this pathway requires 
only 2 components: a periplasmic chaperone and an outer membrane protein termed an 
usher.  
The assembly of P and type I pili, expressed by uropathogenic E. coli, is an 
example of this pathway (Roberts et al, 1994). These pili consist of a thin, flexible tip 
fibrillum connected to a rigid, helical rod. Following export across the inner membrane 
via the Sec pathway, pilus subunits interact with the periplasmic chaperone via a 
conserved carboxy-terminal motif present on each of the pilus subunits. The chaperone 
facilitates release of pilus subunits into the periplasm (Jones et al, 1997). Interaction with 
the usher protein in the outer membrane triggers chaperone dissociation from the subunit, 
allowing incorporation of the subunit into the pilus fiber. The usher provides a 
translocation channel through the outer membrane for secretion of the pilus. 
1.3.5. Type I Secretion 
ATP binding cassette (ABC) transporters, found in eukaryotes and prokaryotes, 
constitute a large superfamily of multi-subunit permeases that transport different 
molecules (ions, amino acids, peptides, antibiotics, polysaccharides, proteins, etc) across 
biological membranes. ABC transporters are classified as importers and exporters 
depending on the direction of translocation of their substrate. The type I pathway is Sec 
 17
 18
independent  and secretes proteins directly from the cytoplasm across the outer 
membrane. Substrates of this pathway lack a cleavable amino-terminal signal sequence. 
Instead, the substrates possess a carboxy-terminal amino acid secretion signal. The type I 
export apparatus consists of two hydrophobic membrane spanning domains (MSDs) 
associated with two cytoplasmic nucleotide binding domains (NBDs). The NBDs of ABC 
transporters bind ATP and couple ATP hydrolysis to the transport process. The MSDs 
consist of four to eight transmembrane α-helices forming a channel allowing the 
translocation of the substrate through the membrane (Braibant et al, 2000). 
An example of a type I ABC exporter is the secretion of hemolysin (HlyA) by 
pathogenic E. coli. HlyA is a lipid-modified polypeptide with a domain that is composed 
of 11-17 nine-amino-acid repeats. The repeat domains bind calcium and are thought to 
interact with host cells, triggering HlyA insertion into the plasma membrane and leakage 
of the cytoplasmic contents of target cells. TolC, the outer membrane protein for 
hemolysin export, assembles as a trimeric complex in the outer membrane as a porin-like 
β-barrel membrane domain with a carboxy-terminal hydrophilic region that extends into 
the periplasm. TolC appears to be involved in several E. coli transport processes such as 
the efflux of antibiotics, heavy metal ions, detergents and solvent (Thanabalu et al, 1998). 
The E. coli genome encodes 57 ABC transporters, of which 44 are importers and 13 are 
exporters. Gram-positive organisms also employ ABC transporters The B. subtilis 
genome encodes 78 ABC transporters, of which 38 are importers and  40 are exporters. 
1.3.6. Type II Secretion 
The type II secretory pathway represents a third terminal branch of the Sec 
pathway. This pathway is responsible for secretion of extracellular enzymes and toxins 
by a wide variety of Gram-negative bacteria. Secretion across the outer membrane by the 
type II branch requires 12 to 16 accessory proteins (Pugsley et al, 1997). The type II 
pathway includes two outer membrane components: GspD, an integral protein and GspS, 
a small lipoprotein required in at least some type II systems for proper targeting and 
insertion of GspD in the outer membrane. Type II substrates cross the inner membrane 
via the Sec pathway followed by signal-sequence cleavage and protein folding in the 
periplasm. The GspD forms a complex with the GspS lipoprotein and serves as a gated 
channel for secretion of substrates to the cell surface. Most of components of the type II 
pathway are associated with the inner membrane (GspC, GspF, GspM, GspL and GspO). 
There are 5 pseudopilins (GspG, GspH, GspI, GspJ and GspK) each with a pilin signal 
peptide that is cleaved by prepilin peptidase (GspO) during Sec-mediated translocation 
across the plasma membrane. GspE is a cytoplasmic protein that localizes to the  inner 
membrane via interaction with GspL, contains a conserved ATP-binding motif and has 
autokinase activity. GspE may regulate secretion or energize the secretion process (Lee 
and Schneewind, 2001). The type II secretion machinery is responsible for secretion of 
proteins across the outer membrane and assembly or retraction of type IV pili. 
1.3.7. Type III Secretion 
Type III secretion is activated by bacterial contact with host cells and is capable 
of translocating antihost factors into the cytosol of target eukaryotic cells. Type III 
secretion is Sec independent, may take place without a periplasmic intermediate, and 
requires about 20 secretion components that assemble into a large structure that spans 
bacterial membranes as well as the host cell membrane (Hueck, 1998). Secretion of 
Yersinia outer proteins (Yops) by Yersinia spp. represents the typical type III export 
pathway. There are 13 Yop proteins of Yersinia species (YopB, D, E, H, M, N, O, P, Q, 
R, T, LcrV and Q) that do not share common peptide sequences and are secreted into the 
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extracellular medium without post-translational modification or cleavage of the 
polypeptide chain. The genes encoding Yops are located on a virulence plasmid. A 
temperature shift to 37ºC, which occurs when bacteria enter the human body, induces 
expression of the type III genes and assembly of the secretion machinery (Cornelis, 
1998).Type III secretion is highly regulated with the first signal appearing to reside in the 
mRNA which may target the RNA-ribosome complex to the type III machinery for 
translation and secretion. The second Yop secretion signal serves as the binding site for 
cytoplasmic chaperones termed Syc proteins and may target Yops to the type III 
machinery for translocation into host cells. Most models for the mechanism of 
translocation across the host cell membrane described a pore formation by YopB and 
YopD proteins. Microscopic detection have revealed that YopE, H, M, O, P and T are 
injected into eukaryotic cells; YopB, D and R are secreted into the extracellular space; 
and YopQ is associated with the bacterial envelope (Cheng and Schneewind, 2000). 
1.3.8. Type IV Secretion 
Type IV transporters mobilize proteins and DNA either from bacteria to bacteria 
or from bacteria to eukaryotic cells. The most common example of type IV secretion 
pathway is the virB system of Agrobacterium tumefaciens that exports T-DNA across the 
bacterial membranes and into plant cells, where the T-DNA integrates into the plant 
genome (Zambryski, 1988).The virB locus consists of 11 genes, 10 of which (virB2 to 
virB11) are critical for DNA transfer. Although virB1 is not essential, deletion of this 
gene attenuates virulence and leads to a lower efficiency of DNA transfer (Berger and 
Christie, 1994). The DNA transport system described for Agrobacterium tumefaciens is 
very similar to a toxin transport system of Bordetella pertussis. This type IV pathway 
consists of nine proteins required for the secretion of pertussis toxin across bacterial 
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membranes. In general, type IV transporters contain 2 proteins (virB4 and virB11) with 
nucleotide-binding motifs, these proteins might serve to signal the opening of a gate or 
channel via kinase activity, or act as molecular chaperones in the assembly of the 
transporter. Presently, very little is known about the series of events that occur during the 
transport process. 
1.4. Protein Secretion Mechanisms in Mycobacteria 
Mycobacterial secreted proteins are translocated across the cytoplasmic 
membrane, transported across the entire cell envelope and released into the extracellular 
space. Exported proteins are those translocated across the cytoplasmic membrane and 
either totally or partially associated with the cell envelope. 
There is currently no evidence of autosecretion, type II, III or IV secretion system 
in M. tuberculosis as described in E. coli and other Gram-negative bacteria. The 
elucidation of the genome sequence of M. tuberculosis demonstrated that this organism 
possesses all the genes required for Sec-dependent translocation of proteins; however, it 
is not known how proteins are further exported through the cell wall of M. tuberculosis. 
The cellular envelope of Mycobacterium species possesses characteristics of the cell 
walls of both Gram-negative and Gram-positive bacteria. The pseudo-bilayer formed by 
the cell wall-attached mycolic acids and outer layer lipids is similar to the outer 
membrane of Gram-negative bacteria, whereas the arabinogalactan covalently attached to 
the peptidoglycan is similar to the cell wall teichoic acids of some Gram-positive bacteria 
(Brennan and Nikaido, 1995). Therefore, the mycobacterial cellular envelope with 
mycolic acids and free lipids represents a formidable obstacle to protein secretion. Some 
of the possible mechanisms that might be active to translocate this barrier are ABC 
transporters, secretin-like proteins and porins (Braunstein and Belisle, 2000). Many 
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putative ABC transporters are encoded by the M. tuberculosis genome; however, since 
ABC transporters can import and export a wide range of molecules, it is difficult to 
predict the transported substrate. Braibant, et al, 2000, reported that the genes encoding 
the ABC transporters occupy about 2.5% of the genome of M. tuberculosis. Contrary to 
E. coli but similar to B. subtilis, there is a relatively equal representation of exporting 
systems versus importing systems in M. tuberculosis (16 importers versus 21 exporters). 
Many of those exporting systems have been implicated in the export of anti-bacterial 
drugs. In addition, there is one exporting system specific to M. tuberculosis and A. 
tumefaciens that could be required for virulence and bacterial attachment to host cells 
(Draper, 1998). 
Several M. tuberculosis proteins identified in the cell wall or culture filtrate are 
known to possess typical N-terminal signal sequences for translocation via the Sec-
dependent pathway. The first evidence of a Sec-dependent pathway in mycobacteria was 
the recognition of N-terminal signal peptides in the predicted amino acid sequences of 
known M. tuberculosis exported and secreted proteins. The second indication that this 
pathway exists in M. tuberculosis came from the identification of homologous secretion 
factors (secA, secD, secE, secF and secY ) encoded by the M. tuberculosis genome 
sequence (Cole et al, 1998). 
Wiker et al, 2000, studied 28 M. tuberculosis secreted proteins and found the 
median signal peptide length was 32 residues, the median n-region length was 9 amino 
acids, the median h-region length was 16 amino-acids and the median c-region length 
was 7 amino acids. In terms of overall amino acid composition, the n-region of M. 
tuberculosis signal peptides is characterized by high arginine content (22%) and a relative 
lower amount of lysine (6%). The arginine-rich n-regions are most likely explained by 
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the high G+C content. Analysis of the preferred amino acids in the positions around the 
cleavage site showed that the mycobacterial signal peptides generally fulfill the (-3,-1) 
rule, with alanine in 19 of 28 signal peptides in position -3 and alanine in 23 of 28 in the 
position -1.   
The only Sec factor apparently lacking in M. tuberculosis is SecB, but this protein 
has been found only in Gram-negative organisms. 
Mycobacterium species possess all the genes required for Sec-dependent 
translocation of proteins; however, M. tuberculosis encodes two homologs of SecA. 
SecA1 and SecA2 contain ATP binding motifs but they are only 34% identical to each 
other at the amino acid level. This sequence difference between the two SecA proteins 
may reflect specific roles played by each in protein translocation (Braunstein et al, 2001). 
Analysis of SecA nucleotide sequence data from different bacterial species has revealed a 
high degree of conservation within the amino-terminus of the predicted protein sequence, 
as well as a similarly conserved ATP binding motif. There are some differences in the 
predicted carboxy-terminal regions, consistent with the likelihood that this portion of the 
SecA protein interacts with the cytoplasmic membrane during the translocation process. 
Owens et al, 2002, were able to build a chimeric form of SecA containing the amino-
terminal end from M. tuberculosis and the carboxy-terminal end from E. coli to 
complement the defective SecA protein in E. coli. The full-length M. tuberculosis secA 
was unable to compensate for the temperature-sensitive (ts) defect, whereas the E. coli 
mutant that had been transformed with the plasmid containing the chimeric secA gene 
was able to grow at 42ºC. This experiment confirms that the N-terminal end of M. 
tuberculosis SecA contains appropriate ATP binding sites and possesses sufficient 
ATPase activity to compensate for the temperature-sensitive defect of the E. coli mutant. 
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There is evidence of mechanisms to transport proteins with recognizable signal 
sequences across the cytoplasmic membrane, however, it is unclear what determines the 
extracellular release or retention in the cell wall (Braunstein and Belisle, 2000). The twin-
arginine pathway is Sec-independent and it is responsible for the translocation of folded 
proteins across the cytoplasmic membrane. The possible presence of a twin-arginine 
translocation system in M. tuberculosis is supported by the observation of homologs to 
components of the twin-arginine system in E. coli (TatA, TatB, TatC and TatD). 
Recently, Dilks et al, 2003, designed a program to predict the presence of Tat substrates 
in bacterial genomes. TATFIND identified 31 open reading frames in M. tuberculosis and 
9 in M. leprae, most of them are hypothetical proteins. 
1.5. General Design of Studies to Identify M. leprae Secreted Proteins. 
The standard approach for studying secretion in cultivable bacteria is to analyze 
cell-free culture filtrates containing truly secreted proteins.  This approach has 
successfully identified approximately 200 secreted proteins in M. tuberculosis but has 
been shown to contain cytoplasmic proteins that leaked into the culture filtrate through 
normal bacterial lysis in culture (Sonnenberg and Belisle, 1997).  While this approach has 
been important in defining major groups of secreted proteins from M. tuberculosis and 
other cultivable mycobacteria, it cannot be applied to studying ML proteins since 
secreted proteins from M. leprae are lost during isolation of the bacilli from infected 
animal tissues. 
Comparative genomics has been another successful approach used to study 
secretion.  By identifying gene homologs in bacterial genomes known to be involved in 
secretion pathways and identifying particular secretory peptide motifs in genes it is 
possible to predict with good accuracy the destination of a selected protein.  I have used 
 24
this approach in my dissertation research by selecting known and predicted secreted 
proteins of M. tuberculosis as a screen for homologous proteins in M. leprae.  The ML 
proteins selected by this approach were then reanalyzed for secretion motifs using 
bioinformatic tools and finally examined for secretion following cloning into either E. 
coli or M. smegmatis.  Secretion of ML proteins was validated by observing the location 
(cytoplasmic vs. extracellular) of a reporter protein (alkaline phosphatase) to which ML 
genes were fused. 
For the purposes of the studies outlined in my dissertation research I have not 
attempted to distinguish between secreted and exported proteins.  Rather, I have used 
bioinformatic tools to predict those proteins of M. leprae that may be secreted via the 
Sec-pathway and that may or may not remain associated with the bacterial cell wall.  
Because M. leprae cannot be grown in vitro, it is impossible to validate the purely 
extracellular location of proteins produced by M. leprae in culture.  Therefore, protein 
secretion in my studies was validated by genetic cloning of predicted secreted ML protein 
genes into plasmid vectors containing reporter genes.  The ML-reporter gene fusions 
were transformed into either E. coli or M. smegmatis to evaluate protein secretion in 
culture. 
1.5.1.Comparative Genomics: M. tuberculosis vs. M. leprae 
The complete genome sequence of M. leprae contains 3,268,203 base pairs (bp), 
and has an average G+C content of 57.8% (Cole et al, 2001). These values are much 
lower than those reported for the M. tuberculosis genome, which comprises 4,000 
genes, 4,411,532 bp and 65.6% G+C (Cole et al, 1998).  The apparent reason for the 
large discrepancy in gene number has to do with M. leprae’s large number of 
pseudogenes. The distribution of the 1,116 pseudogenes in M. leprae is essentially 
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random and preliminary studies have suggested that some pseudogenes may produce 
either partial or complete transcripts (Williams et al, 2003). Of the 1605 genes predicted 
in M. leprae there are 1440 which are also found in M. tuberculosis and 165 genes that 
have no orthologue in M. tuberculosis (Cole et al, 2001). The M. tuberculosis genome 
was the first to be sequenced and revealed an organism with broad metabolic potential; 
most anabolic pathways are present and it has many genes involved in lipid synthesis and 
metabolism. By contrast, the M. leprae genome appears highly degenerate as defined by 
deficiencies in genes for recombination, appears to have fewer lipolytic genes than M. 
tuberculosis, lacks iron scavenging siderophores and is deficient in energy production. 
The major protein families in M. leprae are involved in lipid or polyketide metabolism, 
modification and synthesis of cell envelope components (methyl-transferases, 
glycosyltransferases), transport processes (ABC transporters, MmpL proteins), or in gene 
regulation (TetR, WhiB, two component system response regulators). While most of the 
M. leprae genes have orthologues in M. tuberculosis, there are several that appear to be 
unique and may have novel activities. These include hypothetical proteins, inorganic 
pyrophosphatase, prolyl-tRNA synthetase, uridine phosphorylase, adenylate cyclase, 
cytochrome P450 (Cole et al, 2001).  
Examination of the genome sequence of the leprosy bacillus provides possible 
explanations for some of M. leprae's unique properties. M. leprae has the longest 
doubling time of any known bacteria and cannot be grown in culture, both properties of 
which are potentially due to an extreme case of gene loss through reductive evolution. 
Less than half of the genome contains functional genes, with many pseudogenes showing 
functional counterparts in Mycobacterium tuberculosis. Cole et al, 2001, made the 
assumption that the genomes of M. leprae and M. tuberculosis were once topologically 
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equivalent and aproximately 4.4 Mb in size, as is the case for many other slow-growing 
mycobacteria. Extensive downsizing must have occurred during evolution of the leprosy 
bacillus since its genome is less than 75% of the size of that of M. tuberculosis. Since 
diverging from the last common mycobacterial ancestor, the leprosy bacillus may have 
lost over 2000 genes, and reductive evolution may have defined the minimal gene set for 
a pathogenic mycobacterium.  Based on these data it is reasonable to expect a reduced 
number of secreted proteins from M. leprae as compared to M. tuberculosis.  For my 
study I used a total of 204 M. tuberculosis protein sequences previously characterized as 
secreted to search for homologs in the M. leprae genome. 
1.5.2.Bioinformatics 
Bioinformatics is the field of study in which computer algorithms are used to 
predict properties of proteins. I utilized bioinformatics tools to predict protein location 
(e.g. cytoplasmic, cell membrane, secreted) of M. leprae proteins.  The first tool used 
predicted signal peptides which involves two tasks: 1) given that a sequence has a signal 
peptide, locate the cleavage site and, 2) discriminate between secretory proteins with 
signal peptides and non-secretory proteins. Nielsen et al, 1997, have developed a 
combined neural network approach to the recognition of signal peptides and their 
cleavage sites, using one network to recognize the cleavage site and another network to 
distinguish between signal peptides and non-signal peptides. It is called SignalP. Nielsen 
et al used a list of known secreted proteins taken from SWISS-PROT and divided them 
into prokaryotic and eukaryotic entries. The prokaryotic data sets were further divided 
into Gram-positive eubacteria and Gram-negative eubacteria. 
The output from the signal peptide/non-signal peptide networks, the S score, can 
be interpreted as an estimate of the probability of the amino acid position belonging to a 
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signal peptide, while the output from the cleavage site/non-cleavage site networks, the C-
score, can be interpreted as an estimate of the probability of the amino acid position being 
the first in the mature protein. If there are several C-score peaks of comparable strength, 
the true cleavage site may often be found by inspecting the S-score curve in order to see 
which of the C-score peaks coincides best with the transition from the signal peptide to 
the non-signal peptide region. In order to formalize this and improve the prediction, 
Nielsen et al defined Y as the geometric average of the C-scores and a smoothed 
derivative of the S-score. They found the best discriminator between signal peptides and 
non-secretory proteins to be the average of the S-score in the predicted signal peptide 
region. If this value, the mean S-score, is greater than 0.5, they predict the sequence in 
question to be a signal peptide. 
Signal anchors often have sites similar to signal peptide cleavage sites after their 
hydrophobic (transmembrane) region; therefore, a prediction method can easily be 
expected to mistake signal anchors for peptides. A similar method to predict the location 
and orientation of transmembrane alpha helices based on a hidden Markov model 
(TMHMM) was designed by Sonnhammer et al, 1998. A model for a transmembrane 
orientation consists of 3 states: one for inside loops, one for transmembrane regions and 
one for outside loops. Each state has an associated probability distribution over the 20 
amino acids characterizing the variability of amino acids in the region it models. An 
analysis of the performance of different programs for the prediction of transmembrane 
regions in proteins by Moller et al, 2001, showed that TMHMM is currently the best 
performing transmembrane prediction program. Eighty-five percent of proteins analyzed 
with TMHMM have their membrane spanning regions correctly predicted.  When the 
 28
polarity of their integration into the membrane is included, the number of correct 
predictions is reduced to 70%. 
Gomez et al, 2000, used two algorithms, SignalP and SPScan to predict the 
location of 3,924 M. tuberculosis proteins.  Cutoff values for the computer predictions 
were chosen on the basis of scores assigned to nine known secreted proteins of M. 
tuberculosis that contain a signal peptide. 208 proteins that scored above the cutoff with 
both programs were analyzed with TMpred and PrositeScan and sorted in 3 groups: 52 
proteins were classified as most likely secreted, 25 proteins as transmembrane proteins 
and 16 as lipoproteins. Ten proteins were chosen at random for cloning into a phoA 
fusion vector and screened for alkaline phosphatase activity. The computer predictions 
were confirmed in 90% (9 of 10) of the putatively secreted proteins tested by E. coli 
phoA gene fusion methods. 
A disadvantage of the computer-based approach is that it is limited to only those 
proteins secreted via the general secretory pathway. While many secreted antigens of 
Mycobacterium tuberculosis fall into this category, the presence in culture filtrates of 
proteins lacking secretory signal peptides suggest the existence of other mechanisms of 
protein secretion in M. tuberculosis. 
In this study, I used a bioinformatic strategy to predict M. leprae secreted 
proteins. Two different programs (SignalP and TMHMM) were used to identify proteins 
having secretory signal peptides and appropriate membrane attachment domain for 
secretion. 
1.5.3.Validation of Protein Secretion 
Proteins released by Mycobacterium tuberculosis into the extracellular 
environment have been the focus of investigation to identify antigens that may induce 
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protective immunity or elicit immune responses of diagnostic value. M. tuberculosis 
culture filtrates have been used to identify mycobacterial proteins that induce protection 
against M. tuberculosis infection in animal models (Collins et al, 1988; Hubbard et al, 
1992; Freer et al, 1998; Weldingh et al, 1998).  Culture filtrates have provided a rich 
array of secreted proteins for study from M. tuberculosis and M. bovis, however, because 
M. leprae cannot be grown in vitro similar culture fractions are not available for study. 
Andersen et al, 1991, classified the proteins present in culture filtrates of M. tuberculosis 
into three major groups: extracellular proteins that accumulate in large quantities in the 
medium but are present only in trace amounts in the intact bacilli, secreted proteins that 
are gradually released during growth of the bacilli and cytoplasmic proteins released from 
dead bacteria during the late logarithmic growth phase. Wiker et al, 1991, developed an 
index for individual mycobacterial antigens expressing the ratio between the amount of 
each antigen in culture fluid and in sonicate preparations. There was good agreement 
between signal sequences and measured index. 
More recently, genetic approaches have been applied to identify secreted proteins 
of M. tuberculosis.  These studies involve screening libraries composed of M. 
tuberculosis-reporter gene fusions. By constructing protein fusions with these reporters 
and assaying for activity in colonies growing on plates, the location (intracellular vs. 
extracellular) of a given protein can be determined. Hoffman and Wright, 1985, 
constructed a fusion vector encoding a protein with a modified form of the phoA gene, an 
easily assayable enzyme normally located in the periplasm of E. coli    K-12. PhoA can 
be detected even at low levels in bacterial colonies by use of chromogenic substrate 5-
bromo-4-chloro-3-indolyl phosphate (XP); however, its activity is absolutely dependent 
upon secretion from the cytoplasm. Hoffman and Wright altered the phoA gene, 
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removing its promoter region, ribosome binding site and the complete signal sequence 
encoding region, and showed that the phoA gene can function as a reporter for secreted 
proteins in E. coli. PhoA is also known to function as a reporter for exported and secreted 
proteins in M. smegmatis (Timm et al, 1994). Lim et al, 1995, screened M. tuberculosis 
DNA-phoA fusion libraries respectively by using a phoA reporter shuttle plasmid 
pJEM11 which replicates in E. coli and M. smegmatis.  They found 12 different inserts 
allowing PhoA expression.  Some of the known M. tuberculosis proteins identified were 
the 19kDa lipoprotein, the 28kDa (erp) protein and an enzyme implicated in the 
biosynthetic pathway of fatty acids. Carroll et al, 2000, used the same approach to study 
M. avium secreted proteins. They isolated 100 PhoA recombinants and 15 of these were 
sequenced, most of them exhibited high degree of homology with known M. tuberculosis 
and M. leprae sequences corresponding to phosphate permeases, cutinases, 
glycosyltransferases, multicopper oxidases and putative invasins. Wiker et al, 2000, used 
computational algorithms in combination with gene fusions to identify secreted proteins, 
membrane proteins and lipoproteins of M. tuberculosis. The computer-algorithms were 
used to predict the subset of M. tuberculosis genes that encode exported proteins. Of the 
34 genes identified by the phoA method, 22 were classified to encode potential soluble 
secreted proteins. Among these were some known antigens (fbpB and C, mpt53, mpt64, 
mtb12) as well as 14 novel secreted proteins. Six of the remaining 12 genes were 
predicted to encode membrane lipoproteins and an additional six to encode integral 
membrane proteins. 
In this study, I used a genetic approach to validate secretion of proteins predicted 
for secretion by constructing alkaline phosphatase-ML gene fusions. Both E. coli and M. 
smegmatis were selected as surrogate host to validate secretion of M. leprae proteins 
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because the Sec dependent pathway is similar to M. tuberculosis and M. leprae and these 





Bioinformatics is a newly emerging interdisciplinary research area which may be 
defined as the interface between biological and computational sciences. One of the sub-
disciplines of bioinformatics is the development of new algorithms and statistics to assess 
relationships among members of large data sets. As a consequence of the large amount of 
data produced in the field of molecular biology, most of the current bioinformatics 
projects address structural and functional aspects of genes and proteins. With the 
increasing number of bacterial genomes being sequenced demands are being made upon 
workers to develop new methods to define proteomes of these organisms.  
One group of proteins of great importance is the secreted proteins, given their 
dominant immunogenicity and role in pathogenesis (Closs et al, 1980; Harboe and Nagai, 
1984; Wiker et al, 1986). The large majority of these proteins possess an amino-terminal 
signal sequence that mediates their membrane translocation via the Sec-dependent 
general export pathway. Following translocation, cleavage of the signal peptide by a 
signal peptidase releases the mature protein, provided there are not additional membrane-
spanning segments (Murphy and Beckwith, 1987). Three distinct regions comprise the N-
terminal signal sequence; the charged N-terminus (n-region), the hydrophobic core (h-
region), and the C-terminal cleavage domain (c-region) (von Heijne, 1985). Secreted 
proteins that follow the Sec-dependent general export pathway can be predicted using 
computer algorithms.  
Analysis of Mycobacterium tuberculosis proteins resulted in the observation that 
the culture filtrate of in vitro-grown bacilli contains the majority of dominant antigens 
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(Abou-Zeid et al, 1988; Collins et al, 1988; Hubbard et al, 1992). This procedure cannot 
be applied to M. leprae because the bacilli do not grow in artificial media and secreted 
proteins are lost during isolation of bacilli from tissues. To search for secreted proteins of 
M. leprae, we have compared known and putatively secreted protein sequences of M. 
tuberculosis with the M. leprae genome. Gomez, et al, 2000, identified 52 M. 
tuberculosis proteins by computer-based analysis as most likely secreted. They used 
SignalP and SPScan to predict potential signal peptides, and TMpred to predict the 
presence of membrane-anchoring sequences. This approach identified novel secreted 
proteins that can be characterized for their potential for immunological diagnosis of 
tuberculosis or vaccine design. In this study, I used bioinformatic tools to predict 
M.leprae secreted proteins.  Two different programs were used to identify proteins 
having secretory signal peptides but lacking additional membrane attachment domains: 
- SignalP, Nielsen, et al, 1997, predicts the presence and location of signal 
peptide cleavage sites in amino acid sequences. The method incorporates a 
prediction of cleavage sites and a signal peptide/non-signal peptide prediction 
based on a combination of Neural Networks and Hidden Markov models. 
- Transmembrane Helix Markov model (TMHMM), Sonnhammer, et al, 1998, 
predicts the location and orientation of transmembrane helices (TMH) in 
protein sequences. The number and location of TMH predicts whether a 
protein is secreted or anchored in the membrane. 
2.2.Materials and Methods 
2.2.1.Genome Database 
M. tuberculosis and M. leprae DNA and protein sequences were obtained from 
the Sanger Centre and the National Center for Biotechnology Information (NCBI). 
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2.2.2.Amino Acid Comparisons of M. leprae and M. tuberculosis Proteins 
Comparisons between M. tuberculosis and M. leprae completed genomes were 
restricted to amino acid sequences and were performed using BLASTP (protein vs. 
protein) server from the Sanger Centre. A total of 204 M. tuberculosis protein sequences 
defined as putatively secreted (Sanger Centre) or previously characterized as secreted 
(Gomez et al, 2000 and Wiker et al, 2000) were used to search for homologs in the M. 
leprae genome. Each M. tuberculosis known or putatively secreted protein served as a 
query sequence against the entire database of M. leprae. Final selection of ML proteins 




The SignalP World Wide Web server predicts the presence and location of signal 
peptide cleavage sites in amino acid sequences from different organisms: Gram-positive 
prokaryotes, Gram-negative prokaryotes, and eukaryotes. The method incorporates a 
prediction of cleavage sites and a signal peptide/non-signal peptide prediction based on a 
combination of several artificial neural networks. SignalP V2.0 comprises two signal 
peptide prediction methods, SignalP-NN (based on neural networks, corresponding to 
SignalP V1.1) and SignalP-HMM (based on hidden Markov models). The Neural 
Networks are based on “learning” by adjusting the weights in the network until its 
performance on the training set is acceptable. For example, known secreted proteins are 
used as database to train the neural network to recognize unknown secreted proteins. 
The Hidden Markov Models use general statistical modeling technique for linear 
problems like sequences or time series and have been widely used in speech recognition 
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applications for 20 years. An HMM for proteins consists of a number of states that are 
connected by transition probabilities. Associated with each state is a distribution over the 
20 amino acids. The SignalP server will return 3 different scores between 0 and 1 for 
each position in the sequence: C, S and Y. In addition, the maximal Y-score, maximal S-
score and mean S-score values are given for the entire sequence. If the mean S-score is 
equal or greater than 0.5, SignalP predicts the sequence in question to be a signal peptide. 
- C-score (raw cleavage site score): The output score from networks trained to 
recognize cleavage sites vs. other sequence positions. 
- S-score (signal peptide score): The output score from networks trained to 
recognize signal peptide vs. non-signal peptide positions. 
- Y-score (combined cleavage site score): The prediction of cleavage site location 
is optimized by observing where the C-score is high and the S-score changes from 
high to a low value. The Y-score formalizes this by combining the height of the 
C-score with the slope of the S-score. 
Up to 70 amino acid long N-terminal sequences were analyzed in my dataset using 
the program trained for Gram-positive organisms. If a sequence was predicted to have a 
signal peptide, the cleavage site was predicted to be immediately before the position with 
the maximal Y-score. Discrimination between signal peptides and non-secretory proteins 
was done by using the mean value of the S-score, averaged from position 1 to the most 
likely cleavage site. 
TMHMM (www.cbs.dtu.dk/services/TMHMM-2.0) 
Transmembrane Hidden Markov Model (TMHMM) is a method to predict the 
location and orientation of transmembrane helices in protein sequences, it is based on a 
hidden Markov model. The basic principle is to define a set of states, each corresponding 
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to a region or specific site in the proteins. In the simplest case, a model for a 
transmembrane protein may consist of three states: one for inside loops, one for 
transmembrane regions and one for outside loops. Positively charged residues are 
predominantly found in loops on the cytoplasmic side. Most transmembrane α helices are 
encoded by a long stretch of hydrophobic residues, that are suitable for hydrophobic 
interactions with lipids. Many signal peptides  also have one hydrophobic region. The 
number and location of transmembrane domains predicts whether the protein is secreted 
or anchored in the membrane. The algorithm provides information about the number of 
transmembrane domains along the amino acid sequence and also predicts an extracellular 
or intracellular location of the protein. For example, there are 3 main locations of a 
residue: in the transmembrane helix core (in the hydrophobic tail region of the 
membrane), in the transmembrane helix caps (in head region of the membrane), and in 
loops. A typical secreted protein will show an N-terminal small intracellular portion 
followed by a transmembrane helix (20 to 40 amino acid long) and the remaining 
sequence located extracellularly. Some sequences have no transmembrane helix and they 
are located either extracellularly or intracellularly. 
2.2.4.Comparisons between M. tuberculosis and M. leprae Sequences 
Pairwise alignments of amino acid sequences from signal sequences and mature 
proteins were performed using OmigaTM 2.0 (Oxford Molecular Ltd., www.gcg.com).  
Identification of N-region (positively-charged amino acids), H-region (hydrophobic 
amino acids) and C-region (signal peptidase recognition site) was based on SignalP. 
Transmembrane domains were predicted using TMHMM.  
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2.3.Results 
A total of 204 putatively secreted or known to be secreted proteins of M. 
tuberculosis  were used to identify homologous amino acid sequences in M. leprae. The 
BLASTP analysis showed that 52 of the 204 M. tuberculosis proteins had no match to 
proteins in M. leprae.  Thirty-eight M. tuberculosis proteins were represented by 
pseudogenes or inactive reading frames in the M. leprae genome and 114 M. tuberculosis 
proteins showed amino acid identity of greater than or equal to 40% with proteins in M. 
leprae. These 114 M. leprae proteins were analyzed to predict secretion with 2 computer 
algorithms: SignalP to predict the presence and location of signal sequences, and 
TMHMM to predict the location and orientation of transmembrane helices in protein 
sequences.  Analysis with SignalP identified 32 proteins with a mean S score ≥ 0.5 (Table 
1).  These 32 protein sequences were analyzed with TMHMM resulting in the selection 
of 24 sequences designated with high probability of being secreted based on the presence 
of 1 or zero transmembrane domains in proper orientation with the predicted signal 
sequence (Table 1, gene name in bold letters). The remaining 8 sequences were predicted 
to be either transmembrane or intracellular proteins (Table 1).  Nineteen proteins 
(ML0091, ML0097, ML0098, ML0620, ML0885, ML1339, ML1417, ML1633, 
ML1811, ML2028, ML2055, ML2331, ML2380, ML2450, ML2522, ML2569A, 
ML2591, ML2598 and ML2659) from a total of 24 putatively secreted proteins had a 
typical N-terminal intracellular sequence followed by a transmembrane domain and good 
cleavage site prediction. The remaining five sequences (ML0715, ML1812, ML1923, 
ML2274 and ML2569) showed 0 transmembrane domains and were predicted by 
TMHMM to be secreted based on amino acid composition (Table 1) as well.
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Table 1: M. leprae proteins selected for secretion by SignalP and TMHMM 






5Predicted TMs 6Location 
ML0041     Rv3883c Ala-Leu-Ala 21-22 0.92 1 (417-439) Transmembrane
ML0091 erp Ala-Ile-Ala   22-23 0.95 1 (9-31) Secreted 
ML0097 fbpA Ala-Glu-Ala    42-43 0.69 1 (13-35) Secreted
ML0098 fbpC1 Ala-Lys-Ala    36-37 0.88 1 (7-29) Secreted
ML0175 Rv0982 Ile-Ser-Ala 49-50 0.96 2 (30-52 and 162-84) Transmembrane 
ML0486     Rv2588c Ala-Ser-Arg 23-24 0.74 1 (4-21) Intracellular 
ML0575 Rv0849 Cys-Leu-Ala 39-40 0.75 2 (5-27 and 42-64) Transmembrane 
ML0620 mtb12 Ala-Pro-Ala  52-53 0.5 1 (5-27) Secreted 
ML0715 lpqC Val-Ser-Ala   26-27 0.73 0 Secreted
ML0885 Rv2190c      Ala-Met-Ala 37-38 0.79 1 (12-34) Secreted
ML1010 bcpB His-Gly-Ala   24-25 0.5 0 Intracellular
ML1214       Rv1566c Ala-Tyr-Ala 26-27 0.76 1 (4-26) Intracellular
ML1339 Rv2672     Ser-Gly-Ala 33-34 0.81 1 (13-35) Secreted 
ML1417 Rv2289      Ala-Glu-Ala 25-26 0.83 1 (5-23) Secreted
ML1537     Rv1797 Trp-Gln-Ala 39-40 0.8 2 (7-29 and 44-66) Transmembrane 
ML1633 Rv2223c    Val-Arg-Val 56-57 0.56 1 (30-52) Secreted 
ML1811 Rv1478      Ala-Thr-Ala 31-32 0.85 1 (7-29) Secreted
ML1812 Rv1477     Ala-Thr-Ala 39-40 0.91 0 Secreted
ML1923 lpqF Ala-His-Ser    37-38 0.76 0 Secreted
ML2028 fbpB Ala-Gly-Gly    32-33 0.74 1 (13-35) Secreted
ML2055 modD Ala-Ala-Ala    37-38 0.63 1 (13-35) Secreted
ML2274 Rv0559c     Ala-Leu-Ala 25-26 0.78 0 Secreted
ML2331 Rv3717      Ala-Val-Ala 31-32 0.89 1 (13-32) Secreted
ML2380 Rv0455c      Ala-Val-Ala 30-31 0.84 1 (7-29) Secreted
ML2450 Rv0479c      Ile-Gly-Ala 26-27 0.76 1 (7-29) Secreted
                                                                                                                                                                            (Table continued)
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ML2522 Rv0309      Ala-Gly-Ala 30-31 0.95 1 (5-27) Secreted
ML2569 Rv0237     Ala-Gln-Ala 27-28 0.76 0 Secreted
ML2569A Rv0236A      Val-Gln-Gln 32-33 0.77 1 (7-29) Secreted
ML2591 mce1C Leu-Phe-Ala     38-39 0.56 1 (13-35) Secreted
ML2598 Rv0178    Ala-Gly-Ala 39-40 0.64 1 (20-42) Secreted 
ML2659 Rv0125      Gly-Ser-Ala 32-33 0.87 1 (13-35) Secreted
ML2664 Rv0116c Ser-Val-Ala 28-29 0.69 2 (7-29 and 39-58) Transmembrane 
 
1 Gene names for proteins from MT that have 50% or greater amino acid identity with matched ML protein  
2 The signal peptidase motif represents the site recognized by the signal peptidase. Ala-X-Ala is the conserved motif for signal 
peptidase. 
3 C site represents the amino acid position at which the signal peptidase cleavage site was predicted    
4 This value represents the mean of signal peptide scores.  
5 TM represents number of transmembrane domains for each protein with amino acid position given in parenthesis. 




A group of 8 proteins were identified as most likely not secreted based on 
physical characteristics including amino acid composition and transmembrane domains.  
ML1010 (no transmembrane domain), ML0486 and 1214 (1 N-terminal transmembrane 
domain each) were composed of amino acid seen primarily in proteins located 
intracellularly.  Analysis of ML0041 showed 1 C-terminal transmembrane domain with 
the remainder of the protein predicted to be located extracellularly. Four sequences 
(ML0175, ML0575, ML1537 and ML2664) had 2 transmembrane domains and, 
therefore, were classified as putative membrane proteins. 
The Ala-X-Ala motif for the signal peptidase was conserved only in 15 of 24 
sequences that were predicted to be secreted by SignalP and TMHMM (Table 1). 
Gly or Ser in position -1 was found in 2 sequences and Val or Ser in position -3 was 
found in 5 sequences as alternative signal peptidase recognition sites (von Heijne, 1983). 
Only 1 sequence (ML2569A) from a total of 24 had an amino acid different from Ala, 
Gly or Ser in position -1 and  3 sequences (ML2450, ML2591 and ML2659) had an 
amino acid different from Ala, Val, Ser or Thr in position -3.  The signal sequences 
ranged in size from 21 to 56 amino acids (Table 1). 
A comparison between each of the 24 M. leprae proteins and their M. tuberculosis 
counterparts was performed using the amino acid alignment program from Omiga 2.0. 
Fifteen M. leprae proteins showed 50% or greater amino acid homology for the mature 
protein (not including signal sequence) with the corresponding M. tuberculosis sequences 
(Table 2).  Fourteen of 15 alignments showed that the amino acid identity between 
mature proteins from M. leprae and M. tuberculosis homologs was considerably higher 
than the amino acid identity between signal sequences (Table 2). 
 
 
Table 2: Comparison of the signal sequences and the mature proteins from 





Length  3Signal seq. 
(%Id/%Sim) 
4Mature prot.  
(%Id /%Sim) 
ML0091 236 erp 284 73  86 55 67 
ML0097 330 fbpA 338 63  74 86  92 
ML0098 301 fbpC1 299 44  69 82 89 
ML0620 167 mtb12 168 40  50 58 70 
ML0715 304 lpqC 304 58  62 73 81 
ML0885 374 2190c 385 27  43 60 72 
ML1811 241 1478 241 55  68 80 85 
ML1812 479 1477 472 72  79 79 87 
ML1923 454 lpqF 452 44 47 82 84 
ML2028 327 fbpB 325 67  77 85 91 
ML2274 112 559c 112 64  76 71 82 
ML2331 256 3717 241 58  74 77  84 
ML2380 153 455c 148 57  63 68 76 
ML2569 387 237 388 63  74 74 82 
ML2591 519 mce1C 515 71  82 73 83 
 
1 Length of protein in amino acids. 
2 MT protein that has 50% or greater amino acid identity with matched ML protein. 
3 Comparison alignments between ML and MT signal sequences. Percentages of amino 
acid identities and similarities are indicated for each comparison. 
4 Comparison alignments between ML and MT mature proteins (signal sequences 
removed). Percentages of identities and similarities are indicated for each comparison.  
Signal sequences from M. leprae and M. tuberculosis were aligned to compare the length 
and percentage of arginine in the N-region. Six out of 15 pairs comparisons showed 
identical arginine content in the N-region for M. leprae and M. tuberculosis signal 
sequences (Figure 2). Two signal sequences (ML0620 and ML2274) showed no arginine 
in the signal sequence as did their MT homologs. The remaining ML signal sequences 
ranged in arginine content from 10% to 37.5%. The mean of the arginine content in the 
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Figure 1: Comparison of amino acid sequence identity and similarity between ML 
and MT proteins.
                            Signal sequence                                                                Percentage of                         
arginine (R) in  
the N-region                         
 
ML0091   MPNRRRCKLSTAISTVATLAIA                      37.5%   
Erp      MPNRRRRKLSTAMSAVAALAVA                      50% 
 
ML0097   MKFVDRFRGAVAGMLRRLVVEAMGVALLSALIGVVGSAPAEA  23.5% 
fbpA     MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGA 23.5% 
 
ML0098   MRGLSAVVRVLCVAALAVGVFAAAVLLAGTAGNAKA        22%     
fbpC1    MKGRSALLRALWIAALSFGLGGVAVAAEPTAKA           22% 
 
ML0620   MTMKSIATYAALAIIGAAV                         0% 
Rv2376c  MKMVKSIAAGLTAAAAIGAAA                       0% 
 
Figure 2: Comparison alignments of 15 signal sequences of predicted secreted 
proteins in M. leprae and M. tuberculosis.  
N-region in blue, hydrophobic region in black, cleavage site in red and lipoprotein motif 
in green.  Identification of N-region (positively-charged amino acids), H-region 
(hydrophobic amino acids) and C-region (signal peptidase recognition site) was based on 







ML0715   MNVARWLASVVLAVCLAGCVGRQVSA                  17% 
lpqC     MPWARMLSLIVLMVCLAGCGGDQLLA                  17% 
 
ML0885   MRLGCKHPVVRLIAHFVVGTLVGFAVLSRFFVATAMA       13% 
Rv2190c  MRLDQRWLIARVIMRSAIGFFASFTVSSGVLAANVLA       27% 
 
ML1811   MRHKNFRLINLAGLTAMVAGLIIVVTIPATA             20% 
Rv1478   MRHTRFHPIKLAWITAVVAGLMVGVATPADA             20% 
 
ML1812   MKRPRRGSVSRPTARFVRPAIPSLVSAALLVSLPVLATA     33% 
Rv1477   MRRNRRGSPARPAARFVRPAIPSALSVALLVCTPGLATA     40% 
 
ML1923   MPQPARRTNQRPPRHRTVALAATAALVVTMAPGCAHS       31% 
lpqF     MGPARLHNRRAGRRMLALSAAAALIVALASGCSSAPTPSANA  36% 
 
ML2028   MIDVSGKIRAWGRWLLVGAAATLPSLISLAGG            14% 
fbpB     MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLA            29% 
 
ML2274   MKGTGLAANVAMAAAATVLAAPALA                   0% 
Rv0559c  MKGTKLAVVVGMTVAAVSLAAPAQA                   0% 
 
ML2331   MNTRVSLRIGFRMVVGLLVAALTTITPTAVA             25% 
Rv3717   MIVGVLVAAATPIISSASATPANIAGMVVFI              0% 
 
ML2380   MSRLSTSLCKGAVFLVFGIIPVAFPTTAVA              10% 
Rv0455c  MSRLSSILRAGAAFLVLGIAAATFPQSAAA              20% 
 
ML2569   MAFPRTLIVLAAASALVVTCGHDVAQA                 17% 
lpqI     MAFPRTLAILAAAAALVVACSHGG                    17% 
 
ML2591   MRTLELPNRLRSGLIGVLVVLLIIGVGQSFTSVPILFA      27% 
mce1C    MRTLEPPNRMRIGLMGIVVALLVVAVGQSFTSVPMLFA      27% 
 
2.4.Discussion 
204 M. tuberculosis known secreted and putatively secreted proteins were used to 
search for homologous M. leprae proteins using bioinformatic tools. Fifty-two M. 
tuberculosis proteins did not show any matches with the M. leprae genome while 38 M. 
tuberculosis proteins had homologies with pseudogenes in the M. leprae genome. The 
large number of pseudogenes was not unexpected based on the previously reported 
relatively low number of functional genes and the high number of pseudogenes in M. 
leprae (Cole et al, 2001) (Table 3).  
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Table 3: Comparison of M. leprae and M. tuberculosis genome features. 
Feature M. leprae M. tuberculosis 
Genome size (bp) 3,268,203 4,411,532 
G+C% 57.79 65.61 
Protein-coding genes 1,604 3,959 
Pseudogenes 1,116 6 
Predicted secreted proteins 24 52* 
G+C% secreted prot. genes 60.5 66 
*Gomez et al, 2000. 
One hundred and fourteen M. leprae proteins were identified using the M. 
tuberculosis protein homolog search.  Analysis with SignalP and TMHMM identified 24 
M. leprae proteins meeting the criteria for secretion.  Five of these genes encode 
authentic secreted proteins in M. tuberculosis (fbpA, B and C, erp and mtb12) supporting 
the validity of this approach for selecting secreted proteins from M. leprae. 
TMHMM is currently one of the best performing transmembrane prediction 
programs and is especially good at reliably distinguishing between soluble intracellular 
and transmembrane proteins (Moller et al, 2001). Eighty-five percent of biochemically 
characterized membrane proteins analyzed with TMHMM by Moller et al, 2001, were 
predicted correctly. The number of predicted secreted proteins for M. tuberculosis  and 
M. leprae (Table 3) resulting from the computer-based approach appears low compared 
to the 200 plus M. tuberculosis proteins found in culture filtrates. However, the low 
number of predicted ML secreted proteins does correlates with the fact that the 
algorithms used in this study detect only those proteins secreted via the Sec pathway. 
While many secreted antigens of M. tuberculosis are translocated via the Sec pathway, 
the presence in culture filtrates of proteins lacking secretory signal peptides (ex.; ESAT-
6, sodA, glnA and katG ) suggests the existence of other mechanisms of protein secretion 
in Mycobacterium spp. For example, ESAT-6 secreted antigen, which is present in M. 
tuberculosis, virulent M. bovis and has been recently identified in M. leprae (Spencer et 
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al, 2002), is a member of a family of 100-amino acid proteins with sequence similarity 
focused on a central WXG motif. Members of this family have been identified in several 
Gram-positive pathogens (e.g.; S. aureus and B. anthracis) and may be components of a 
surface-located secretion apparatus. By analogy with Gram-negative mechanisms of 
secretion, this apparatus might be assembled only under specific conditions (e.g., contact 
with host cell) (Pallen, 2002). Since M. leprae has homologs of ESAT-6, sodA and glnA, 
this secretory system may also be functional in M. leprae adding to its potential number 
of total secreted proteins. 
Four of the 24 M. leprae proteins predicted to be secreted using SignalP and 
TMHMM were previously described M. tuberculosis and M. leprae proteins: ML0097 
fibronectin-binding protein (fbpA), ML2028 (fbpB) and ML0098 (fbpC); and ML2591  
(mce1C), one of the genes of the mammalian cell entry operon. The fibronectin-binding 
proteins (fbpA, fbpB and fbpC) stimulate the uptake of mycobacterial bacilli by human 
macrophages by interacting with the gelatin binding site of human fibronectin (Abou-
Zeid et al, 1988) and also have cell wall mycolyltransferase activity (Belisle, et al, 1997). 
Arruda et al, 1993, described a DNA fragment of M. tuberculosis that conferred 
to a non-pathogenic E. coli strain the ability to gain entry into mammalian cells and to 
survive inside macrophages. The mammalian cell entry (mce) gene was termed mce1. 
Analysis of the M. tuberculosis genome revealed four copies of mce, situated in operons 
of 8 genes each. 
The erp gene known as exported repetitive protein was identified in M. bovis 
culture supernatants by Western blot (Bigi et al, 1995). Erp is a secreted antigen from M. 
tuberculosis required for virulence (Berthet et al, 1998). Together the fibronectin-binding 
proteins (fbpA, fbpB and fbpC), mce1C and erp represent secreted virulence factors of M. 
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tuberculosis and M. bovis.  My study shows that they are also predicted to be secreted in 
M. leprae, however, further studies will be necessary to confirm whether they represent 
virulence factors in M. leprae. 
The generally accepted Ala-X-Ala motif for signal peptidase was conserved in 15 
of 24 ML sequences that were predicted to be secreted by SignalP and TMHMM (Table 
1). Gly or Ser in position -1 was found in 2 sequences and Val or Ser in position -3 was 
found in 5 sequences as alternative signal peptidase recognition sites (Saleh, et al, 2001). 
Only 1 sequence (ML2569A) from a total of 24 had an amino acid different from Ala, 
Gly or Ser in position -1, and  3 sequences (ML2450, ML2591 and ML2659) had an 
amino acid different from Ala, Val, Ser or Thr in position -3 (Table 1). These results are 
in agreement with Wiker, et al, 2000, who showed that M. leprae signal peptides have 
similar cleavage site motifs to those found in M. tuberculosis signal peptides. Four 
sequences from a total of 24 do not fit the model described by Saleh et al, 2001. It is 
possible that signal peptidases from M. leprae may accept amino acids not present in the 
conventional model described for cleavage site motif. 
Fifteen M. leprae proteins showed 50% or greater homology for the mature 
protein (not including signal sequence) with the corresponding M. tuberculosis sequences 
meeting my requirement for further analysis (Table 2). Fourteen of these alignments 
showed that the homology between mature proteins is considerably higher than the 
homology between signal sequences.  The mean identity between ML and MT homologs 
for mature proteins was 73.5% and only 57% for signal sequences. These data correlate 
with the fact that signal peptides from Gram-positive bacteria are considerably longer and 
more variable than those from other organisms (Nielsen et al, 1997). Harboe and Wiker, 
1999, searched for secreted proteins from M. leprae by comparing DNA sequences from 
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M. tuberculosis  and M. leprae prior to the completion of the ML genome. They 
identified only 10 sequences (fbpA, fbpB, fbpC, mpt32, mpt51, erp, mtc28, mtb12, 
Rv3354 and Rv0526) with high homology between M. tuberculosis and M. leprae. My 
study showed that 5 of 10 sequences predicted to be secreted by Harboe and Wiker (fbpA, 
fbpB, fbpC, erp and mtb12) plus 19 other proteins were predicted to be secreted using the 
criteria set for secretion.  Harboe and Wiker’s analysis was performed prior to the 
completion of the M leprae genome leaving their analysis incomplete.  In addition, they 
used an older version of SignalP and no algorithm to predict the presence of 
transmembrane domains. Nevertheless, their conclusions and my results are in 
agreement. For example, they reported that the genomic organization of genes for 
secreted proteins was similar in M. leprae and M. tuberculosis and that amino acid 
homologies between ML and MT secreted proteins was found to be higher for the mature 
polypeptide chains than for the corresponding signal peptides.  
My study showed that differences between amino acid identities of ML and MT 
signal sequences were 15.4 %.  The same comparison for ML and MT mature proteins 
was 8.13 %. These data are consistent with the concept that similar amino acids can 
substitute for various signal sequence motifs (positively-charged, hydrophobic, etc.)  
Similarly, mature proteins may allow fewer amino acid substitutions because of stringent  
functional and structural requirements needed for structural or enzymatic activity. 
Six out of 15 pairs of amino acid sequences showed the same percentage of 
arginine at the N-region for M. leprae and M. tuberculosis proteins (Figure 1). The 
arginine rich N-regions are most likely explained by the high G+C content found in 
mycobacterial genomes and related preferred codon usage. It is interesting to note that 
even though M. leprae has a much reduced overall genome G+C content (57.8%) 
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compared to M. tuberculosis (65.6%), several secreted proteins identified in this study 
had G+C% ratios in the order of 60% (Table 3). One possible explanation for the 
difference between ML G+C content and MT G+C content might be that the ML genome 
suffered a considerable loss of G+C in pseudogenes during reductive evolution. This 
assumption agrees with the fact that the G+C content of functional ML genes is higher 
than the G+C content of the overall ML genome (Table 3).  
In summary, 204 M. tuberculosis known and predicted putatively secreted 
proteins were used to search for homologous M. leprae proteins. The computer-based 
analysis showed that 24 M. leprae proteins were predicted to be secreted. These data 
suggest that Sec-dependent secretion is operative in M. leprae and is closely related to 
commonly described Sec-dependent secretion in other Gram-positive microorganisms. 
The cleavage-site motif for the signal peptidase was conserved in 20 of 24 ML proteins 
studied and showed that M. leprae signal sequences were very similar to M. tuberculosis 
signal sequences.  
Fifteen M. leprae proteins showed 50% or greater homology with their 
corresponding M. tuberculosis gene sequences and were selected for gene expression 
studies (Chapter 3). Comparison alignments between M. tuberculosis and M. leprae 
protein sequences showed that homologies between mature proteins are considerable 
higher than homologies between signal sequences. Analysis of amino acid composition of 
the N-region for both M. leprae and M. tuberculosis showed a high arginine content 
which is consistent with the high G+C content of mycobacterial genes. In terms of amino 
acid composition, my analysis showed that signal sequences from M. leprae were similar 
to M. tuberculosis signal sequences. 
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CHAPTER 3 
M. LEPRAE GENE EXPRESSION AND SECRETION IN E. COLI AND M. 
SMEGMATIS 
3.1.Introduction 
 Secreted proteins represent a distinct group of proteins with respect to their structure, 
function and contribution to virulence. They are of particular importance for vaccine 
development because they are often immunogenic and have the potential to be recognized 
early in infection. A requisite step in protein secretion is protein translocation across the 
cytoplasmic membrane. This step is common to proteins that are released to the extracellular 
space or remain associated with the cell wall. The Sec-dependent pathway translocates 
precursor proteins containing N-terminal signal sequences across the cytoplasmic membrane 
(Oliver and Beckwith, 1981).  
Secretion systems in mycobacteria are important for the proper localization of 
structural and metabolic components as well as virulence factors. However, little is known 
about this aspect of mycobacterial physiology. In particular it is not known how proteins 
escape from the cell wall of mycobacteria or how proteins lacking N-terminal signal 
sequences are exported. The first evidence of a Sec-dependent pathway in mycobacteria was 
the recognition of N-terminal signal peptides in the predicted amino acid sequences of known 
M. tuberculosis and M. leprae secreted proteins (Harboe and Wiker, 1999; Gomez et al, 
2000). The second indication that this pathway existed in M. tuberculosis and M. leprae 
came from the identification of genes (Cole, et al, 1998) with sequence homology to known 
proteins involved in Sec-dependent secretion in E. coli (Braunstein, et al, 2001).  
The completion of the M. leprae genome sequence has provided investigators an 
opportunity to use bioinformatics tools to predict gene function by comparing translated 
protein sequences of M. leprae with those of other bacteria. Comparative genome analysis 
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has provided new information about the Sec-dependent pathway in M. tuberculosis and M. 
leprae including the presence of two SecA homologues (SecA1 and SecA2) (Braunstein et 
al, 2001). Comparative genomics coupled with other bioinformatics tools, such as SignalP 
and TMHMM can predict protein location in the bacterial cell and may aid approaches 
designed to identify proteins with diagnostic or vaccine potential. As powerful as these tools 
are they can only make predictions based on characteristics previously identified in proteins 
with predetermined functions such as secretion. New unknown proteins may meet some but 
not all of the critical characteristics sought and, therefore, may be excluded from analysis. 
Alternatively, a protein may have unique characteristics not recognized by a particular 
algorithm and, therefore, may not be secreted in vivo even thought it is predicted for 
secretion in silico.  Therefore, experimental validation is critical when using bioinformatics 
tools for identifying proteins with potential for secretion. 
Once various genes have been identified using bioinformatics tools it is important to 
verify that the gene is expressed during intracellular growth.  Identifying M. leprae genes 
expressed during infection helps focus attention on bacterial factors necessary for survival 
and growth within the human host, thereby increasing our understanding of the host-
pathogen interaction. Gene expression has been studied in M. tuberculosis during infection 
by reverse transcription-polymerase chain reaction (RT-PCR) and microarray analysis 
(Mariani et al, 2000; Triccas and Gicquel, 2000). Virulent mycobacteria must adapt to 
adverse conditions encountered during the infectious process. This means, at a mechanistic 
level, that the amount of some bacterial proteins must be increased in response to the 
changing environment and the amount of others must be lowered. The inability to culture M. 
leprae represented a major obstacle to obtaining sufficient quantities of mRNA to perform 
global gene expression analysis using conventional approaches. Just recently, new techniques 
 52
to isolate highly viable bacteria from infected foot pad tissue have evolved that make 
possible gene transcription analysis in M. leprae using gene specific RT-PCR based analysis 
of mRNA (Truman and Krahenbuhl, 2001). 
The most direct approach  for studying secretion is to identify expressed proteins in 
the extracellular space experimentally.  For example, secretion can be studied in cultivable 
bacteria by analyzing cell-free culture filtrates containing exported proteins. While this 
approach has successfully identified major groups of secreted proteins from M. tuberculosis, 
it cannot be applied to studying ML proteins since M.leprae cannot be grown in vitro.  
Secreted proteins from M.leprae surely exist and are exported to the surrounding tissues 
during infection; however, these proteins are lost when M.leprae is isolated from infected 
tissues. Hibridization in situ with antibodies is another approach for studying secretion in 
intracellular bacteria because it can be done in tissue.  A new approach for studying secretion 
is to take advantage of the properties of enzymes (e.g. alkaline phosphatase and β-lactamase) 
that require translocation across the cell membrane to be detected.  These genes can be fused 
to unknown genes and act as a reporter in biological systems.  For example the alkaline 
phosphatase (phoA) gene lacks a promoter, ribosome binding site (RBS) and export leader 
sequence.  Fusion of phoA to an M. leprae gene supplying the missing upstream components 
will result in secreted proteins which when expressed will have detectable PhoA activity.  
Identification of reporter activity in bacterial colonies implies that the cloned fragment 
supplies all three functions and, therefore, contains a portion of a gene encoding a secreted 
protein. Alkaline phosphatase fusions have been used successfully to identify M. tuberculosis  
(Lim et al, 1995) and M. avium exported proteins (Carroll et al, 2000) in a surrogate 
organism, M. smegmatis. A similar approach using a β-lactamase gene and an upstream tac 
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promoter was used to identify M. tuberculosis exported proteins in E. coli (Chubb et al, 
1998).  
This chapter describes the results from gene transcription studies of 15 ML proteins 
predicted to be secreted using SignalP/TMHMM (Chapter 2). The mRNA was purified from 
M. leprae grown in nude mice and gene transcription was monitored by RT-PCR. Each gene 
was cloned into 2 separate reporter plasmids in an attempt to demonstrate proteins secretion 
in either E. coli or M. smegmatis.  
3.2.Materials and Methods 
3.2.1.Bacterial Strains and Culture Conditions 
 M. leprae T-53 was isolated from a lesion of an untreated lepromatous leprosy patient 
in Thailand in 1982 and maintained  in serial-passage in the hind foot pads of athymic nude 
mice (Hsd:Athymic Nude, Harlan, Indianapolis, IN) at the Laboratory Research Branch of 
the National Hansen’s Disease Programs, Baton Rouge, LA.   
 E. coli XL-1 Blue supercompetent cells (Stratagene, La Jolla, CA) were cultured in 
LB Lennox agar or broth (Life Technologies, Rockville, Maryland) supplemented with 
antibiotics (ampicillin, 100 ug/ml or kanamycin, 50 ug/ml, Sigma-Aldrich Co., St Louis, 
MO). M. smegmatis mc2 155 (ATCC, Rockville, Maryland) was cultured in Middlebrook 
7H9 broth supplemented with Tween 80 (Difco Laboratories, Detroit, MI) for electroporation 
and Middlebrook ADC (Becton, Dickinson and Company, Sparks, MD) or Luria Agar 
Miller’s modified (Alpha Biosciences, Baltimore, MD) supplemented with kanamycin 
50ug/ml.  Both media contained 5-Bromo-4-Chloro-3-Indolyl Phosphate (BCIP) at 40 ug/ml 





 pQUANTagen (Qbiogene, Carlsbad, CA)  is a fusion vector that contains a mutated 
version of the E. coli alkaline phosphatase gene under the transcriptional control of the 
synthetic tac promoter and the lacI repressor (Figure 3). The alkaline phosphatase gene is out 
of frame in the vector and the reading frame is restored upon correct insertion of a cloned 
DNA fragment. A BamHI-BglII site containing the sequence for the signal peptide for PhoA 
in pQUANTagen that directs the fusion protein to the periplasm in pQUANTagen was 
removed to study secretion and is referred to as pQUANTagen-sphoA. The plasmid also 
carries the β-lactamase gene conferring ampicillin resistance for selective growth in E. coli.  
 pJEM11 was a gift from Denis Portnoi, Pasteur Institute, France. It has a phoA 
reporter shuttle plasmid, origins of replication (ori) for E. coli and mycobacteria and a 
multiple cloning site upstream of the phoA gene. The selectable marker is a kanamycin 
resistance gene (Km). The truncated phoA gene is devoid of a promoter, start codon and 
signal sequence. The expression and exportation of PhoA depends on translational fusion 
with amino termini of other proteins encoding the necessary sequences. 
3.2.3.Purification of M. leprae  
 Bacteria were harvested from foot pad tissue using a modification of a previously 
described protocol by Truman and Krahenbuhl, 2001.  Briefly, the hind feet were soaked in 
ethanol for 1 min and the granulomatous foot pad tissue was removed,  minced to a uniform 
consistency with curved scissors and homogenized thoroughly for 1 min in a sterile tissue 
grinder (Fisher/Pyrex, Houston, TX) containing 5 ml of cold  Middlebrook 7H12 medium 
(Difco/Becton Dickinson, Sparks, MD).  Excess tissue was removed by centrifugation at 200 
x g  for 1 min at 4° C and the bacteria remaining in the supernatant fluid were pelleted at 
10,000 x g for 10 min at 4° C. The pellet was resuspended in 10.5 ml Middlebrook 7H9 broth 
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(Difco/Becton Dickinson) containing ampicillin (50ug/ml) and held for 3 hours at 37° C. An 
aliquot was removed for acid-fast staining and counting (BBL7 TB Ziehl-Neelsen Kit, 
Becton Dickinson Microbiology Systems).  All M. leprae preparations were analyzed and 
determined to be free of microbial contaminants by culturing the final M. leprae suspension 
on a variety of media including: blood agar, Lowenstein-Jensen, thioglycolate broth and 
trypticase soy broth (Becton Dickinson Microbiology Systems, Cockeysville, MD) for up to 
2 weeks. 
3.2.4.Purification of M. leprae and M. smegmatis RNA  
 RNA was purified from 2 x 10P10P M. leprae T-53 or M. smegmatis mc P2 P 155 using a 
modification of a previously described protocol by Hellyer et al, 1999. Aliquots containing 2 
x 10P9 P M. leprae or M. smegmatis were transferred to sterile RNAase-free 2 ml 
microcentrifuge tubes (Sarstedt, Newton, NC) and pelleted by centrifugation at 10,000 x g 
for 10 min at 4° C.   Bacterial pellets were resuspended in 80 µl of DEPC-HB2 BO (Sigma-
Aldrich Chemical Co. St. Louis, MO).  TRIzol® Reagent (Invitrogen, Carlsbad, CA) (920 µl) 
was added to each tube to maintain the RNA integrity while disrupting cells and dissolving 
cell organelles; the contents were transferred to a FastRNAP®P Blue tube (FastRNAPTMPKit-Blue, 
Qbiogene, Carlsbad, CA).  Bacterial cells were lysed and total RNA was extracted by 
homogenization in a FastPrepP®P FP120 Instrument (Qbiogene) for 45 sec at a speed setting of 
6.5. Tubes were cooled for 5 min, then this procedure was repeated and the tubes were held 
on ice for 5 min.  A 200 µl aliquot of chloroform/isoamyl alcohol (CIA) (24:1) (Sigma 
Aldrich) was added to each tube and tubes were mixed by vortex for 1 min.  The glass matrix 
was pelleted by centrifugation at 700 x g for 5 min and the top, aqueous layer was transferred 
to a new 1.5 ml microcentrifuge tube.  Cleanascite HC (CPG Biotech, Lincoln Park, NJ) (100 
µl) was added to the each tube and the tubes were mixed on a rocking platform for 10 min.  
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The Cleanascite was pelleted by centrifugation at 10,000 x g for 1 min and the supernatant 
fluids were added to fresh 1.5 ml tubes containing 500 µl CIA and vortex mixed for 10 sec.  
The phases were separated by centrifugation at 10,000 x g for 2 min and the top aqueous 
phase was transferred to a 1.5 ml microcentrifuge tube.  GlycoBlue™ co-precipitant, 
(Ambion, Inc., Austin, TX) (1 µl), 1/10 volume of 5M NH B4 BOAc and an equal volume of cold 
isopropanol were added. The tubes were mixed and the RNA was precipitated at –80° C 
overnight.  RNA was collected by centrifugation at 10,000 x g for 10 min at 4° C and  the 
pellets were washed in 500 µl of salt/ethanol wash solution (FastRNAPTMP Kit-Blue),  air-dried 
for 10 min and dissolved in 50 µl of DEPC-treated water (FastRNAPTM PKit-Blue).  RNA was 
pooled and DNA was removed from these preparations using the DNA-free™ kit (Ambion, 
Austin, TX). Briefly, 50 µl aliquots of RNA were treated with 2 units of DNase (Ambion) at 
37ºC for 1 hr, the reaction was stopped with Dnase inactivation reagent (Ambion) and 
centrifuged for 1 minute at 10,000 rpm to pellet the reagent. Purified RNA was transferred to 
a new 1.5 ml tube and stored at -80°C.   
 3.2.5.Reverse Transcription of M. leprae RNA 
 Total RNA was converted to cDNA with random hexamer primers and MMLV 
reverse transcriptase (Advantage RT-for-PCR Kit, BD Biosciences, Clontech, Palo Alto, 
CA),  according to manufacturer’s recommendations. Briefly, primers and RNA were 
incubated at 70ºC for 2 minutes followed by 5 minutes at 4ºC. The master mix containing the 
reverse transcriptase was added and the reaction was incubated at 44ºC for 1 hr, heated at 
94ºC for 5 minutes to stop cDNA synthesis and to destroy any DNase activity; and 
resuspended in a final volume of 100 µl.  A control for monitoring genomic DNA 
contamination in the RNA extract consisted of RNA incubated with the reverse transcription 
reagents as described above excluding the reverse transcriptase (RT-).  cDNA was also made 
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from BALB/c mouse spleen total RNA (BD Biosciences, Clontech) and human peripheral 
blood mononuclear cell RNA. These cDNAs were used as specificity controls for M. leprae 
genes by PCR assays. 
3.2.6.PCR Amplification  
 M. leprae T-53 (107 AFB) were disrupted by 3 cycles of freezing and thawing at  
-70ºC for 15 minutes and 95ºC for 5 minutes.  DNA in the disrupted bacterial suspension was 
used as template to amplify 15 ML predicted secreted genes that were found to have > 50% 
amino acid identity with M. tuberculosis proteins (Table 2).  PCR primers and amplification 
protocols were designed for M. leprae genes by acquiring gene sequences from the M. leprae 
genome database at the Sanger Centre (www.sanger.ac.uk) and using OmigaTM 2.0 Primer 
Design software (Oxford Molecular Ltd, Madison, WI).  PCR assays were initially 
characterized for specificity using 1 ng M.  leprae T-53 DNA and  mouse spleen cDNA.  
PCR fragments were separated by gel electrophoresis on 2% NuSieve GTG-SeaKem GTG 
(1:1) agarose gels (BioWhitaker, Rockland, ME) in TAE buffer (4 M Tris-acetate, pH 8.0, 1 
mM EDTA). Ethidium bromide-stained gels were visualized by UV transillumination and 
photographed using a GelDoc®2000 Instrument (Bio-Rad Systems, Hercules, CA). The 
amplicons were purified using QIAquick PCR columns (QIAGEN, Valencia, CA) and DNA 
sequences of PCR  fragments were obtained by automated DNA sequencing on an Applied 
Biosystems sequencer (GeneLab, SVM, LSU, Baton Rouge, LA).  Transcription analysis was 
performed by PCR (40 cycles) using cDNA from M. leprae as template and gene specific 
primers for amplification.  PCR conditions were denaturation at 94º C for 30 seconds, 
annealing for 1 minute at Tº (temperature determined by Omiga 2.0 Primer Design software) 
and primer extension at 72º C for 2 minutes. 
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3.2.7.Cloning ML Genes into pQUANTagen 
 M. leprae T-53 DNA was used as template for initial gene specific PCR 
amplification.  PCR conditions were 40 cycles of denaturation at 94º C for 30 seconds, 
annealing for 1 minute temperature determined by Omiga, 1Pst P PCR, Table 4 and primer 
extension at 72º C for 2 minutes. The PCR products were separated and purified as described 
above. A 2 PndP PCR, used to amplify the gene of interest was performed on the purified 
amplicon from the 1Pst P PCR as template using primers containing restriction enzyme sites for 
cloning into pQUANTagen (Figure 3). PCR conditions were the same as those used for the 
1Pst P PCR with the annealing temperature set at 60º C for all of the genes amplified in the 2PndP 
PCR. Fifteen M. leprae genes encoding predicted secreted proteins were amplified from the 
start codon (ATG or GTG) to a few bases before the stop codon for cloning into 
pQUANTagen. Amplification primers included two different restriction sites for 
unidirectional cloning except when using BamHI with BglII (Table 4). PCR products were 
purified and digested with appropriate restriction enzymes (New England Biolabs, Beverly, 
MA) for cloning (Table 4) and separated by gel electrophoresis on 0.8% NuSieve GTG-
SeaKem GTG (1:1) agarose gels. Restricted pQUANTagen vector and PCR fragments were 
purified from agarose gels using QIA quick Gel Extraction kit, Qiagen. Ligation was 
performed at a molar ratio of 2:1 (insert:vector) with 1unit of T4 ligase (Invitrogen, Carlsbad, 
CA) at 14ºC overnight. Recombinant plasmid DNA was introduced into E. coli XL-1 blue 
supercompetent cells by transformation (Stratagene, La Jolla, CA). Briefly, 100ul of cells 
were placed in prechilled 15 ml tubes for each transformation. β-mercaptoethanol 
(Stratagene) 1.7ul was added and cells were held on ice for 10 minutes.  The ligation mixture 
(10ul) was added to each tube and then held on ice for 30 minutes. The tubes were incubated 
at 42ºC for 45 seconds (heat pulse) and then held on ice for 2 minutes.  SOC medium 
(Qbiogene, Carlsbad, CA) (0.9 ml) was added to each tube followed by incubation at 37ºC 
for 1 hour with shaking at 225 rpm. The transformation mixture was plated on Luria agar, 
supplemented with ampicillin and BCIP. ML gene-pQUANTagen recombinant plasmids 
were screened for phoA expression in E. coli XL-1 blue cells. Blue colonies were recovered 
at day 2 and restreaked to obtain single-colony isolates. Transformants were screened for 
carriage of pQUANTagen recombinant derivatives with ML gene insert by PCR of frozen 
and thawed (3X) bacterial lysates. Primers for PCR detection of ML insert (Figure 2) were 
designed using OmigaTM 2.0. DNA sequences of PCR  fragments were obtained by 
automated DNA sequencing on an Applied Biosystems sequencer (GeneLab, SVM, LSU, 
Baton Rouge, LA). 
 
Figure 3: Map of pQUANTagen.The PhoA signal sequence (sphoA) corresponding to 
BamHI (nucleotide position 1570)-BglII (nucleotide position 1711) was removed from the 
original vector before cloning to create pQUANTagen (- sphoA). In some cases the plasmid 
was cut with BsrGI (nucleotide position 1585) when ML genes that showed BamHI sites 
within the gene. The plasmid was cut with KpnI (nucleotide position 1735) or SalI 
(nucleotide position 1726) when ML genes showed BglII sites in the restriction map of the 
gene (Table 4).The tac promoter is located upstream of the phoA gene. Primers for DNA 
sequencing were located at nucleotide position 1525 (forward primer: 5’- 




3.2.8.Cloning ML Genes into pJEM11  
 Fifteen M. leprae gene sequences were screened for putative promoter areas using the 
Gene and Functional Signal Finding Program ( HTUwww.softberry.comUTH) and 10 genes were 
selected for cloning into pJEM11 based on the presence of potential upstream elements for 
promoter activity. pJEM11 is a  phoA reporter shuttle plasmid which replicates in E. coli and 
M. smegmatis and expresses kanamycin resistance in both genetic backgrounds (Figure 4). 
Primers containing BamHI restriction sites were designed for cloning into pJEM11 (3Prd P PCR, 
Table 4). PCR conditions were the same as used for the 1Pst P PCR (Table 4), but the annealing 
temperature was 60º C for all genes amplified. PCR products were purified and digested with 
BamHI. pJEM11 was digested with BamHI and dephosphorylated with calf-intestine alkaline 
phosphatase (CIP). PCR products and pJEM11 were purified from agarose gels as described 
above. Recombinant plasmids were propagated in E.coli XL-1 blue. Plasmid DNA from 
colonies recovered on LB plus kanamycin plates was isolated using a QIAprep spin miniprep 
kit (Qiagen). Purified plasmid DNA was introduced into electrocompetent M. smegmatis mc P2 
P155 cells by electroporation using a Bio-Rad Gene Pulser (Hercules, CA) following a 
previously described protocol by Cirillo et al, 1993. Briefly, a culture (400ml) of M. 
smegmatis mcP2 P155 was grown at 37ºC for 2 days with constant shaking until reaching mid 
log growth (approximately 48 hrs.). The culture was held on ice for 1 hour and then 
centrifuged for 10 minutes at 5,000 x g at 4 ºC. The pellet was washed with cold 10% 
glycerol three times and the final bacterial pellet was resuspended in 1 ml of 10% glycerol. 
 One-hundred ul of this cell suspension and 50 ng of DNA were placed in 1.5 ml 
polypropylene tubes for each electroporation. The Gene Pulser apparatus was set at 2.5 kV, 
25uF and 900 Ω. After delivering the pulse, the cell/DNA mixture was transferred to a 
culture tube containing 1 ml of 7H9 plus ADC and incubated at 37ºC with constant shaking 
for 2 hours. Recombinant M. smegmatis colonies were screened for phoA expression on 
Luria agar containing kanamycin and BCIP. Blue colonies were recovered on days 7-14 and 
restreaked to obtain single-colony isolates and confirm phoA reporter activity. Transformants 
were screened for carriage of pJEM11 recombinant derivatives by PCR as described above 
with pQUANTagen recombinants. Primers in the multiple cloning site and E. coli phoA gene 
sequence were designed with OmigaTM 2.0. DNA sequence of ML genes were obtained by 
automated DNA sequencing on an Applied Biosystems sequencer (GeneLab, SVM, LSU, 
Baton Rouge, LA) 
 
Figure 4: Map of pJEM11. pJEM11, a phoA reporter shuttle plasmid, has origins of 
replication (ori) for E. coli and mycobacteria and a multiple cloning site (MCS) upstream the 
phoA gene, represented by BamHI site. The selectable marker is the kanamycin resistance 
gene (Km). The truncated phoA gene is devoid of the promoter, start codon and signal 
sequence; the expression and exportation of PhoA depends on translational fusion with 
amino termini of other proteins encoding these sequences. The transcriptional terminator 
avoids transcription by read-through from plasmid sequences. Primers for DNA sequencing 
were located at the multiple cloning site (forward primer: 5’-CTAGTACTGGGCCCGCGG 
AT-3’) and E. coli phoA gene (reverse primer: 5’-CCCCATCCCATCGCCAAT-3’ 
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Table 4: Primers used for PCR cloning ML genes into plasmid vectors 
Gene name 1PstP PCR from ML lysates P1 P2Pnd P PCR P2 P3Prd P PCR
 AT  Ampl Primers  5’→ 3’ Ampl R.E. Ampl*
ML0091          
 




692 BamHI-BglII       603 
ML0097 60  1301  CAGGAATTTTAGACAGGCATCG 
AGCCCCTAAATACTGCTGAAGG 
973 BamHI-BglII     813 
ML0098 60  965   CTTGCATCGAATCATCG 
CCTCCCTAGCGAATGG 
919 BamHI-BglII     640 
ML0620 60  516  GATACGAAAGACCAGGAACAAGG 
CGACACGGAAACGTCAGC 
418 BamHI-BglII     514 
ML0715 62  1054    TTCAACCCTGACCGCACC 
GAAAAACTGCGCGATAACTTCC 
901 BamHI-BglII     670 
ML0885 58  1392     CTCTGTTGCAGGATGAACG 
ACCCGACGAATTCATCG 
1073 BamHI-KpnI     865 




735 BsrGI-BglII     --- 
ML1812 65  1572   TGCAGTTTGTGACTTGCGTTTCC 
TATTCGATGTAGCGGACCACATACG 
1349 BsrGI-SalI     950 
ML1923 64  1219    TCGCTGCTGGAATTCGAGG 
CCCGATATACGGCCATTTGC 
1200 BsrGI-KpnI     --- 
ML2028 61  1383    CGTAAGACAACCGCTGAGG 
GGGGTACAGCCATCAAGG 
983 BamHI-BglII     750 
ML2274 60  340  AAGTATATCATCCGGCTTATGAAGG 
GTTGCAGGATGCCTATTTGG 
340 BamHI-BglII     --- 
ML2331 60  747   AACACACGAGTTAGCCTCCGTATCG 
GGCAAGGAAGCCCTCGACG 
688 BamHI-BglII     --- 
                                                                                                                                                                               (Table continued) 
 
ML2380 60  512      GTTCCTGCTGGCTCGTAAGC 
TGGTACTGGTTGCAAACCTCG 
455 BamHI-BglII    512 
ML2569 60  1502    ACGAGTCCGCCAGCGTTTTTACC 
CCTTCTCTAGCCGGTCCAAGACTGC 
969 BamHI-BglII    850 
ML2591 65  1555       GCTGGAACTCCCCAATCG 
TACTCAATTCCGACTACCTCCTGC 
1417 BsrGI-BglII    --- 
AT: Annealing temperature  
* Length of amplicon of first, second and third PCR in base pairs (bp) 
R.E: Restriction enzymes used for cloning into pQUANTagen. 
---- Gene was not cloned in pJEM11 because there was no putative promoter region identified. 
1 A second PCR was performed on the purified amplicons from the first PCR using primers containing appropriate restriction sites for 
cloning into pQUANTagen. 
2 A third PCR was performed on the purified amplicons from the first PCR using primers containing BamHI sites at the 5’ and 3’ ends. 
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3.2.9.Detection of mRNA for ML Genes Cloned into M. smegmatis 
 Primers specific for each ML gene that was successfully cloned in pJEM11(ML0091, 
ML0097, ML0098, ML0715, ML2028, ML2380 and ML2569) were designed to amplify a 
fragment from each M. smegmatis transformant cDNA.  mRNA expression analysis was 
performed using cDNA from M. smegmatis transformants and the same conditions for first 
PCR assay as described above. 
Table 5: Primers and amplicon sizes for 7 ML genes cloned in M. smegmatis for mRNA 
transcript analysis. 
 
Gene name Amplicon (bp) Primers* 5’→ 3’ 


















ML2380 250 GGATTTTCCGATCCCCCGC 
CCAATGCGTGGCCATCTGCT 
ML2569 430 GCCACGATGTTGCACAGGCT 
TTGTGACCACGGTCCAGCG 
* Specific primers designed to amplify a portion of each gene. Annealing temperatures were 
60ºC except for ML2028 which was 65ºC. 
 
3.2.10.ML Protein Expression in M. smegmatis and E. coli 
Late log  cultures of recombinant E. coli and M. smegmatis were harvested by 
centrifugation at 6000 x g (4ºC) for 15 minutes.  Culture supernatants were precipitated with 
iced-cold 100% ethanol (Sigma), the precipitate collected by centrifugation at 11,000 x g (4º 
C) for 30 minutes and the pellet was dried and resuspended in 100ul PBS.  Bacterial pellets 
were washed 3 times with phosphate buffered saline, pH 7.4 (PBS) and resuspended in 0.5 
ml of PBS. M. smegmatis samples were sonicated (3 cycles of 10 minutes at 50% power) 
using a microtip sonicator with an Ultrasonic Homogenizer 4710 (Cole-Parmer Instrument 
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Co., Chicago, IL).  The bacterial sonicates were span at 11,000 x g (4º C ) for 10 minutes and 
the supernatants were transferred to clean tubes.  Total proteins of culture filtrates and 
bacterial sonicates were measured by BCA Protein Assay (Pierce, Rockford, IL) using BSA 
as a standard.  
Concentrated culture supernatants and bacterial sonicates (200 µg) were analyzed by 
immunobloting after separation of proteins on 10% polyacrylamide gels containing sodium 
dodecylsulfate (SDS-PAGE). Sonicates and culture filtrates mixed (1:1) with sample buffer 
(62.5mM Tris-HCl, 10% glycerol, 2% SDS, 0.05% β-mercaptoethanol, 0.05% bromophenol 
blue) and loaded onto gels.  SDS-PAGE gels were run for 2 hours at 25 mA and 2 hour at 50 
mA in a Protean II xi cell (Bio-Rad, Hercules, CA) and blotted on Immobilon-P transfer 
membrane (Millipore, Bedford, MA) using a trans-blot cell (Bio-Rad) overnight at 12 V in 
Tris-glycine buffer containing 30% methanol (Sigma). The membrane was blocked with 3% 
BSA (Sigma) in PBS at room temperature for 45 minutes followed by incubation at room 
temperature for 2 hours with mouse anti-E. coli alkaline phosphatase monoclonal antibody 
(Chemicon International, Inc., Temecula, CA), diluted 1:2500 in 1% BSA in PBS. The 
membrane was washed 3 times with PBS containing 0.05% Tween 20 (Sigma), incubated at 
room temperature for 1 hour with horseradish peroxidase (HRP) conjugated goat anti-mouse 
immunoglobulins (Dako Corp., Carpenteria, CA) diluted 1:2000 in 1% BSA in PBS. The 
membrane was washed again as stated above and placed in HRP color development reagent 
(30 mg of 4-chloro-1-naphthol) (Bio-Rad)  in 10 ml of methanol, 300 µl of 3% hydrogen 
peroxide (Medic, Jacksonville, FL) and 50 ml of Tris-buffered saline, pH 7.5 at room 




3.3.1.Gene Expression of 15 Putatively Secreted Proteins in M. leprae during Infection 
in the Nude Mouse 
Fifteen ML predicted secreted proteins that showed 50% amino acid homology with 
M. tuberculosis (Table 2) were selected for studying gene transcriptionion in M. leprae 
during intracellular growth in the nude mouse by RT-PCR.  Amplicons produced by RT-PCR 
showed predicted DNA fragment sizes for each of the 15 genes tested.  An example of one 
RT-PCR gene transcript analysis is shown in Figure 5.Both the cDNA (lane 2) and genomic 
DNA (lane 5) produced amplicons of the appropriate size (450 bp) for the ML0097 (fbpA) 
gene. DNA sequencing of the amplicon confirmed the existence of fbpA mRNA in M. leprae 
during infection of nude mice. Mouse cDNA and RT(-) ML samples were run as negative 
controls for each gene (Figure 4). These data confirm that all 15 M. leprae genes identified as 
putatively secreted proteins are transcribed during infection and, therefore, may be critical for 
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Figure 5: Agarose gel electrophoretic analysis of PCR products of ML0097 (fbpA) from 
ML genomic and cDNA derived from ML-infected nude mice.  Lane 1 1kb ladder, lane 2 




3.3.2.Cloning ML Genes into pQUANTagen 
15 ML genes were amplified by PCR (Table 4) for cloning into pQuant (- sphoA), a 
vector that contains the alkaline phosphatase gene under the transcriptional control of the 
synthetic tac promoter. The signal peptide for phoA that directs the fusion protein through the 
membrane to the periplasm of E. coli was removed to study secretion of the 15 ML 
putatively secreted proteins (Figure 3) in E. coli.  Ligation mixtures for each gene were 
transformed into E. coli XL-1 blue supercompetent cells and produced between 100-200 
Ampr transformant colonies.  All ML gene transformants produced blue and white colonies 
on agar plates supplemented with the substrate for the alkaline phosphatase with the 
percentage of blue colonies per transformant ranging from 10% to 70%.  
3.3.3.PCR Amplification and Sequence Analysis of M. leprae Inserts in pQUANTagen 
 
For each ML gene E. coli transformation ten colonies were pooled and used to 
inoculate LB plus Amp media.  Plasmid DNA from these cultures were purified, amplified 
by PCR with primers designed for sequencing in pQUANTagen and were analyzed on 
agarose gels.  PCR products that matched gene insert size (Table 6, Figure 6) were sequenced 
starting 30-40 bases upstream of the ML gene start codon to authenticate gene orientation 
and reading frame. Blue colonies recovered from E. coli transformants ML0091, ML0097, 
ML0620, ML1811 and ML1812, and white colonies from one E. coli transformant ML2380 
confirmed proper gene insert and alignment for expression (Table 6).  While proper gene 
insert and alignment were found for ML0091, ML0097, ML1811 and ML1812 sequences 
were incomplete finishing before the stop codon for each gene.  DNA sequencing from only 
two gene inserts ML0620 and ML2380 verified the presence of the complete gene inserts 
(Table 6).  DNA from E. coli transformants ML0098, ML0715, ML0885, ML1923, ML2028, 
ML2274, ML2331, ML2569 and ML2591 each produced a PCR fragment of about 300bp  
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indicating the absence of a ML gene insert (Table 6 and Figure 6). An example of two E. coli 
transformants containing ML genes ML0091 and ML0097 is shown in Figure 6.  E. coli 
transformants produced amplicons of the appropriate size for the ML0091 (992 bp ) and 
ML0097 (1273 bp) genes and where no insert was detected showed a band at 300 bp. 
Table 6: ML PhoA gene fusions in E. coli 




ML0091 (erp) blue 992 620 
ML0097 (fbpA) blue 1273  510 
ML0098 (fbpC) 1--- 300 --- 
ML0620 (mtb12) blue 718 Complete gene 
ML0715 (lpqC) --- 300 --- 
ML0885 --- 300 --- 
ML1811  blue 1035 620 
ML1812  blue 1649 470 
ML1923 (lpqF) --- 300 --- 
ML2028 (fbpB) --- 300 --- 
ML2274 --- 300 --- 
ML2331 --- 300 --- 
ML2380 2white  755 Complete gene 
ML2569 --- 300 --- 
ML2591(mce1C) --- 300 --- 
 
1 Low percentage of blue colonies all testing negative for gene inserts, all white colonies 
tested showed no gene insert. 
2 Low percentage of blue colonies all tested negative for gene insert, some white colonies 
tested positive for gene insert. 
* ML gene inserts amplified by PCR with pQUANTagen primers have amplicon sizes of 2nd 
PCR (Table 4) plus multiple cloning site from pQUANTagen (300bp). ML genes with no 
insert identified by PCR showed amplicon size of 300bp, the same as the multiple cloning 
site of pQUANTagen. 
** DNA sequences of cloned genes from PCR products yielding predicted amplicon sizes 
were determined beginning 30-40 bases upstream of ML gene start codon and finishing after 
the ML gene stop codon (ML0620 and ML2380) or before the ML gene stop codon 
(ML0091, ML0097, ML1811 and ML1812). 
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Figure 6: Agarose gel electrophoretic analysis of PCR products from E. coli 
transformants containing ML genes.  Lane 1, ML0091 (992 bp), lanes 2 and 3, 
transformants without insert, lanes 4, 1kb ladder , lane 5 pQUANTagen plasmid, lane 6 
ML0097 (1273 bp). 
3.3.4.Cloning ML Putatively Secreted Protein Genes into pJEM11 
Because pJEM11 contains a truncated phoA reporter gene without a promoter, start 
codon and signal sequence (Figure 4), 10 ML genes (ML0091, ML0097, ML0098, ML0620, 
ML0715, ML0885, ML1812, ML2028, ML2380 and ML2569) were selected for analysis in 
pJEM11 based on their putative possession of the required genetic elements. These 10 ML 
genes (Table 4) were amplified by PCR and cloned into pJEM11.  Each ligation mixture was 
first transformed into E. coli XL-1 Blue supercompetent cells from which 50-100 Kanr 
transformant colonies were recovered for each ML gene.  For each cloned gene plasmid 
DNA was purified from a culture grown from a pool of colonies and introduced into mc2155 
by electroporation. Twenty to forty Kanr  M. smegmatis transformants colonies were 
recovered from Luria agar plates containing BCIP. Blue colonies, representing M. smegmatis 
transformants capable of exporting alkaline phosphatase, were identified from transformants 
ML0715 and ML2569 (Table 7 and Figure 7). White colonies, representing M. smegmatis 
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transformants without a gene insert or with a gene insert lacking all or some of the required 
genetic elements for transcription, translation or secretion, were identified from 
transformants ML0091, ML0097, ML0098, ML0620, ML0885, ML1812, ML2028 and 
ML2380 (Table 7). 
3.3.5.PCR Amplification and Sequence Analysis of M. leprae Inserts in pJEM11 
 DNA from each of ten colonies from M. smegmatis transformants for each ML gene 
was amplified by PCR with primers for sequencing in pJEM11 (Figure 4). PCR products 
from all clones except (ML0620, ML0885 and ML1812) matched predicted gene insert sizes 
(Table 7) and were sequenced starting 30-40 bases upstream of ML gene start codon and 
finishing from 400 to 800 bases before the ML gene stop codon.  ML genes with correct 
orientation and reading frame were confirmed for the first 380 bp of M. smegmatis 
transformant ML0715 and the first 430 bp of M. smegmatis transformant ML2569. Also, ML 
gene inserts with correct orientation and reading frame were confirmed in 5 M. smegmatis 
transformant (white colonies) by sequencing the first 395bp (ML 0091), 430 bp (ML0097), 
180 bp (ML0098), 210 bp (ML2028) and 200 bp (ML2380) (Table 7).  Plasmid DNA from 
three M. smegmatis transformants yielding white colonies (ML0620, ML0885 and ML1812) 
produced PCR fragments of 250bp indicating the absence of a gene insert (Table 7). The 
analysis of promoter areas showed that 4 of 10 ML genes (Table 7) did not have identifiable 
RBS, -10 or -35 regions in the 200 bp segment analyzed suggesting that these 4 genes may be 
located within discrete operons. 
Table 7: ML PhoA gene fusions in M. smegmatis. 
 
Gene name ML gene 
insert** (bp)




ML0091 (erp) 853 RBS white 395 
ML0097 (fbpA) 1063 RBS white 430 
                                                                                                                         (Table continued)
 
ML0098 (fbpC) 890 RBS, -10 white 180 
ML0620 (mtb12) 250 NI2 white ---1
ML0715 (lpqC) 920 -10, -35 blue 380 
ML0885 250 RBS, -10, -35 white --- 
ML1812  250 NI white --- 
ML2028 (fbpB) 1000 -10, -35 white 210 
ML2380 762 NI white 200 
ML2569 1100 NI blue 430 
 
1 No gene insert identified by PCR. 
* RBS were identified by The Sanger Centre annotation of ML genome and –10 and –35 
regions were identified using the Gene and Functional Signal Finding Program, SoftBerry 
(www.softberry.com). 
** ML gene inserts amplified by PCR with pJEM11 primers have the size of amplicon sizes 
of 3rd PCR (Table 4) plus multiple cloning site from pJEM11 (250bp). ML genes with no 
insert identified by PCR showed amplicon sizes of 250bp, the same as the multiple cloning 
site of pJEM11. 
^DNA sequences of cloned genes from PCR products yielding predicted amplicon sizes were 
determined beginning 30-40 bases upstream of ML gene start codon and finishing before the 
ML gene stop codon. 
2 NI, nothing identified resembling a promoter or ribosome binding site 
 
Agarose gel electrophoresis analysis of PCR fragment sizes for two pJEM11 cloned genes is 
shown in Figure 8.  ML DNA from M. smegmatis  transformants produced amplicons of the 
appropriate size for the ML0091 (853 bp) and ML0715 (920 bp) genes. Clones containing 





     pJEM11           ML2569 
 
Figure 7: Colonies of M.smegmatis following pJEM11 transformation by 
electroporation.  Transformants were plated in Luria agar with Kan and BCIP. Inset of plate 
ML2569 shows close-up of 2 blue colonies and a white colony. 
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Figure 8: Agarose gel electrophoretic analysis of PCR products from M. smegmatis 
transformed with pJEM11-ML gene fusions.  
Lane 1 and 2, transformants ML0091, lanes 3 and 12 1kb ladder , lanes 4 and 5 transformants 
ML0715, lanes 6 and 7 transformants with no insert, lanes 8, 9, 10 and 11 pJEM11 plasmid. 
3.3.6.Transcription of ML Genes Cloned into M. smegmatis 
 
Because 5 M. smegmatis transformants contained a portion of a cloned ML gene but 
produced white colonies on culture, RT-PCR was employed to determine whether gene-
specific mRNA was present in growing M. smegmatis cells.  cDNA from total RNA was 
prepared using specific primers for each ML gene (ML0091, ML0097, ML0098, ML0715, 
ML2028, ML2380 and ML2569) cloned into M. smegmatis.  mRNA from ML0715 was 
identified by PCR using a forward primer made from ML0715 gene sequence and a reverse 
primer made from E. coli phoA gene sequence (Table 5).  Authentic ML gene sequences 
were confirmed by sequencing the PCR products. 
An example of detecting mRNA from an M. smegmatis transformant containing 
ML0097 is shown in Figure 9. DNA and cDNA from M. smegmatis  transformant ML0097 
produced a 450 bp amplicon confirming transcription in M. smegmatis (Table 5).  Negative 
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Figure 9: Agarose gel electrophoretic analysis of RT-PCR products derived from cDNA 
from M. smegmatis transformants. Lane 1, RT (-), lane 2 pJEM11, lane 3 ML0097 DNA 
amplified with specific primers. Lanes 4 and 5 M. smegmatis transformant ML0097 cDNA 
amplified with ML 0097 gene specific primers, respectively. Lane 6 contained 100 bp ladder. 
3.3.7.Immunoblot Detection of PhoA Fusion Proteins in M. smegmatis and E. coli 
Lysates prepared from recombinant E. coli clones (ML0091, ML0097, ML0620, 
ML1811 and ML1812) producing blue colonies on BCIP containing media were tested by 
immunoblotting for expression of ML-PhoA fusion proteins.  Bacterial sonicates prepared 
from recombinant M. smegmatis clones (ML0715 and ML2569) producing blue colonies and 
recombinant M. smegmatis clones (ML0091, ML0097, ML0098, ML2028 and ML2380) 
producing white colonies on BCIP-containing media were also tested by immunoblotting for 
expression of ML-PhoA fusion proteins.  A recombinant E. coli strain producing high levels 
of native PhoA was used as a positive control.   
Immunoblots of E. coli transformants ML0620, ML0097 and ML0091 identified a 
band at approximately 50 kDa corresponding in size with native E. coli alkaline phosphatase 
(Fig 10).  ML0620-phoA and ML0097-phoA fusions showed a second band at approximately 
63 kDa and 84kDa, respectively (Fig 10).  These protein bands corresponded to their 
respective predicted molecular weights for each ML-phoA fusion protein.  ML0091-phoA 
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fusion showed two other bands at approximately 55 kDa and 90 kDa, neither of which 
corresponded to the predicted molecular weight for the authentic ML0091-phoA fusion of 73 
kDa.  Extracts from E. coli transformant ML0098, in which a cloned insert could not be 
identified by PCR (Table 6), showed no bands detectable by immunoblotting (Fig 10).  
Culture filtrates containing 200 ug of protein from cultures of all recombinant clones were 
tested by immunoblotting and showed no detectable bands under identical conditions used 
above (data not shown).  
All attempts to identify fusion proteins in extracts from recombinant M. smegmatis 
clones were unsuccessful (data not shown).  Both bacterial sonicates and culture filtrates 
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Figure 10: Western blot of M. smegmatis and E. coli ML transformants. 
Lysates from M. smegmatis and E. coli transformants were electrophoretically separated on 
10% SDS-PAGE, transferred to Immobilon-P membrane and reacted with 1:2,500 dilution of 
monoclonal anti-phoA  Lane 1 MW marker, lane 2 is native E. coli phoA, lanes 3, 4, 5 and 6 




Characterization of exported proteins in M. leprae is important because it will provide 
a better understanding of the signals that direct proteins to the cell membrane, to the cell wall 
and to the bacteria’s surrounding immediate exterior as soluble secreted proteins. Some of 
the exported proteins are involved in the building of the mycobacterial cell wall, such as the 
antigen 85 complex (fbpA, B and C), but the majority of exported proteins have not been 
functionally characterized.  A comprehensive study of exported proteins in mycobacteria is 
needed to identify those proteins involved in cell envelope biogenesis, immunogenicity and 
virulence.  In efforts to identify ML secreted proteins this work has explored the utility of 
bioinformatic tools for predicting secretion in M. leprae and has explored the usefulness of 
secretion vectors for the identification and validation of secretion of proteins in E. coli and 
M. smegmatis.  
Fifteen ML proteins that showed greater than 50% amino acid sequence homology 
with a known or predicted M. tuberculosis secreted protein were selected for studying gene 
expression in M. leprae during intracellular growth in the nude mouse. All 15 putatively 
secreted protein genes were transcribed in M. leprae during infection suggesting that all 15 
M. leprae genes are likely critical for maintenance of intracellular survival during infection. 
Seven of the M. leprae proteins identified in my study have been shown previously to be 
associated with virulence in M. tuberculosis  (fbpA, B and C, Rv2190c similar to ML0885, 
Rv1477 similar toML1812, Rv1478 similar to ML1811 and mce1C), correlates with the 
observation of Finlay and Falkow, 1997, and Miller and Cossart, 1999, who showed that the 
majority of virulence factors in bacteria are extracytoplasmic proteins.   
Williams et al, 2003, studied gene expression of over 200 ML genes during infection 
in nude mice. The study included genes involved in Sec-dependent secretion, DNA 
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replication, transcription, virulence factors, iron acquisition and numerous metabolic 
pathways. While only a small percentage of the 1600 potential genes of M. leprae were 
studied greater than 90 percent of the genes analyzed were transcribed. These data supported 
earlier speculation that since M. leprae has undergone a rather severe loss of genes due to a 
reductive evolutionary process, the remaining genes of M. leprae may define a minimal set of 
genes necessary for growth and survival of an intracellular mycobacterial pathogen. 
Accordingly, the relatively low number of potentially secreted proteins identified in my 
dissertation studies is in keeping with this interpretation. It is interesting to note that only 271 
genes were necessary for survival of the free-living nonpathogen, B. subtilis (Ehrlich et al, 
2003). Comparisons between minimal gene sets of free-living and pathogenic bacteria may 
help define genetic elements important in intracellular survival and help elucidate pathogenic 
mechanisms of mycobacteria and other intracellular pathogens.  
PhoA fusion studies using a modified pQUANTagen without the phoA signal 
sequence, showed that 5 ML proteins (ML0091, fbpA, ML0620, ML1811 and ML1812) 
produced blue colonies and, therefore, were secreted in E. coli. Nine ML genes (fbpC, lpqC, 
ML0885, lpqF, fbpB, ML2274, ML2331, ML2569 and mce1C) were unable to be cloned in 
E. coli.  A simple explanation for these results is that the 9 unclonable mycobacterial proteins 
were toxic for E. coli.  Jobling, et al, 1997, reported that the production of wild type cholera 
toxin as a periplasmic protein was toxic for E. coli, but by replacing the native signal 
sequence with an E. coli signal sequence they were able to produced cholera toxin protein in 
high yield in E. coli.  While the ML proteins were clearly not toxins like cholera toxin, many 
proteins are difficult to clone in E. coli for myriad reasons involving such as blockage of 
metabolic pathways to binding and disrupting membranes and others physiologically 
important structures.  For example, E. coli may be unable to process mycobacterial 
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lipoproteins or other Sec-dependent motifs found in some ML signal peptides, leading to 
build up of these proteins eventual toxicity to E. coli.  
PhoA fusion studies using pJEM11 showed that only 2 proteins (ML0715 and 
ML2569) produced blue colonies and, therefore, were secreted in M. smegmatis. Both 
proteins are thought to be lipoproteins based on the presence of a conserved motif.  Lim, et 
al, 1995, used pJEM11 to construct an M. tuberculosis DNA library of fusions to the PhoA 
gene and identified a sequence corresponding to the exported 19kDa lipoprotein. 
Lipoproteins have been found in both Gram-negative and Gram-positive bacteria; however, 
differences in the conserved motif of lipoproteins or in the specificity of signal peptidase II to 
process lipoproteins may exist in E. coli making secretion impossible.  
The low number of detectable ML proteins secreted by M. smegmatis could be related 
to the presence of mutations or deletions in the ML genes that produced an out of frame ML 
gene-phoA fusion.  The sequence data for the 7 ML genes cloned in M. smegmatis is not 
complete, therefore, it is possible that all or some white colonies are M. smegmatis 
transformants carrying mutations of the ML genes resulting in defective phoA fusions.  The 
expression of PhoA from pJEM11 in M. smegmatis depends on translational fusion with 
amino termini of the cloned ML proteins and the presence of a functional promoter. Of 10 
ML genes that were selected for cloning into pJEM11, only 4 showed a putative promoter 
area (-35 and -10 sites) located 100 to 200 bases upstream from the starting codon. However, 
strict definition of mycobacterial promoters is still undefined and the potential for some of 
these genes to be within operons can not be ruled out.  
Three ML proteins (ML0620, ML0885 and ML1812) were unable to be cloned in M. 
smegmatis and may be due to procedural issues. It is possible that some ML genes require 
specific environmental conditions (e.g. intracellular) for expression or for their product to be 
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exported. In addition, at the level of promoter recognition and transcription initiation 
controlled by the sigma factors of RNA polymerase, there may be significant differences 
between M. leprae and M. smegmatis blocking gene expression. Comparative genomic 
studies of M. leprae and M. tuberculosis have shown a significantly lower number of sigma 
factors in M. leprae (Cole et al, 2001).  
The E. coli and M. smegmatis secretion vectors were available for this study and were 
used before to validate secretion in M. tuberculosis.  E. coli vector showed more ML proteins 
secreted (5 out of 6) under a strong E. coli promoter. In addition, the alkaline phosphatase 
activity was detected in 2 days in Luria agar supplemented with the appropriate substrate. A 
disadvantage of using E. coli is the incompatibility to process post translational modifications 
(e.g. lipoproteins).  M. smegmatis vector showed less ML proteins secreted (2 out of 7), and 
maybe due to weak ML promoters. The alkaline phosphatase activity was detected after 7-14 
days in Luria agar supplemented with the appropriate substrate. 
The Sec pathway for secretion is present in both M.leprae and E. coli but there appear 
to be some differences. For example, the absence of SecB and the presence of two SecA 
genes in Mycobacterium spp (Braunstein et al, 2001) could make the process of translocation 
slightly different. SecB acts as a chaperone and binds SecA, but it has been only found in 
Gram-negative bacteria. By comparison mycobacteria and some other Gram-positive bacteria 
code two SecA proteins. It is thought that the two proteins might be involved in exporting 
different subsets of proteins. In addition, the signal sequences for secretion described for 
Gram-negative and Gram-positive bacteria are not identical. Therefore, some of the 
mycobacterial signal sequences might not be recognized by the E. coli Sec-dependent 
pathway. Taken together these differences may explain why 9 of 15 ML proteins were not 
expressed in E. coli. 
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In order to study gene expression in M. smegmatis as a function of transcription, RT-
PCR was performed. Transcripts were identified for 7 ML genes cloned in M. smegmatis 
(ML0091, ML0097, ML0098, ML0715, ML2028, ML2380 and ML2569). These data 
confirm that the required genetic elements for transcription are present in pJEM11.  
White colonies recovered from M. smegmatis transformants (ML0091, ML0097, 
ML0098, ML2028 and ML2380 might represent mutants resulting in a defective phoA fusion 
or transformants lacking the required genetic elements for translation or secretion. In order to 
study protein expression of the 5 recombinant M. smegmatis white colonies immunoblot 
detection of phoA fusion proteins was performed. Under these conditions, ML recombinant 
protein was not observed in the blots. These results suggest that the phoA gene is not in frame 
with some or all the M. smegmatis white transformants due to mutations in ML genes.  The 
M. smegmatis blue transformants showed alkaline phosphatase activity in Luria agar plates 
and therefore have a functional phoA gene, however, the transcription of phoA may be under 
a weak promoter. ML0091, ML0097 and ML0620 recombinant proteins from E. coli 
transformants were identified by immunoblot detection with monoclonal antibodies anti-
PhoA, ML0620 complete sequence was confirmed in E. coli. 
The experiments in this dissertation showed indirect evidence of Sec-dependent 
mechanisms for secretion in M. leprae. The possibility that some or all of these ML secreted 
proteins were translocated in E. coli or M. smegmatis by a different secretion pathway (Ex. 
Sec-independent pathway), cannot be ruled out. 
In summary, the analysis of PhoA fusions validated 5 of 6 ML proteins (83%) in E. 
coli and 2 of 7 ML proteins (29%) in M. smegmatis. By comparison, Gomez et al, 2000, 
identified 52 M. tuberculosis predicted secreted proteins by computer-based analysis and 9 of 
10 (90%) were confirmed using PhoA gene fusions in E. coli. These results suggest that 
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predictions for secretion in M. leprae using Signal P and TMHMM are useful in selecting 
Sec-dependent secreted proteins.   
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CONCLUSIONS 
1) Bioinformatic Tools Predict Sec-dependent Protein Secretion in M. leprae 
Bioinformatic tools trained to recognize secreted  proteins were used to predict the 
existence of secreted proteins in M. leprae.  Sequences for two hundred and four M. 
tuberculosis proteins either known to be or predicted to be secreted constituted the set of 
gene sequences from which M. leprae homologs were selected.  Fifty-two MT proteins were 
not found in the M. leprae genome and 38 MT proteins were related to ML pseudogenes. 
Analysis of the remaining 114 homologs with SignalP and TMHMM predicted that 24 ML 
proteins display characteristics consistent with secretion via the sec-dependent protein 
secretion pathway. 
M. leprae signal sequences were found to be very similar to other Gram-positive and 
M. tuberculosis signal sequences.  Cleavage sites were conserved and the N-regions from 
ML signal sequences showed a high arginine content (19%) similar to that found in M. 
tuberculosis (22%) Sec-dependent secreted proteins. 
Many fewer secreted proteins were predicted in M. leprae (24) compared to M. 
tuberculosis (52). This discrepancy is also observed in the number of functional genes in M. 
tuberculosis (3959) compared to M. leprae (1604) and may be the result of a severely 
diminished genome in M. leprae due to evolutionary pressures.  These data supported earlier 
speculation that since M. leprae has undergone a severe loss of genes due to a reductive 
evolutionary process, the remaining genes of M. leprae may define a minimal set of genes 
necessary for growth and survival of an intracellular mycobacterial pathogen.  
2) All 15 ML Predicted Secreted Proteins Were Transcribed During Intracellular 
Growth in Nude Mice 
Analysis of M. leprae growing in nude mice identified transcripts for all 15 putatively 
secreted protein genes of M. leprae.  Seven of these M. leprae proteins have been associated 
82 
with potential virulence factors in M. tuberculosis and correlates with the observation that the 
majority of bacterial virulence factors are extracytoplasmic proteins. 
3) Secretion of 83% of the ML Predicted Secreted Proteins Was Verified by PhoA 
Fusion Analyis in E. coli and Secretion of 29% of the ML Predicted Proteins Was 
Verified by PhoA Fusion Analysis in M. smegmatis 
By comparison, Gomez et al, 2000, identified 52 M. tuberculosis predicted proteins 
using bioinformatic tools and 90% were verified by phoA fusion analysis in E. coli. These 
results suggest  that predictions for secretion in M. leprae using bioinformatics tools are 
useful in selecting Sec-dependent secreted proteins.  My data also suggest that validation of 
secretion in M. smegmatis can help extend coverage of potential secreted proteins to include 
lipoproteins of M. leprae. 
Future studies will be directed to investigate the relevance of the two ML lipoproteins 
(ML0715 and ML2569) secreted in M. smegmatis and the 5 ML proteins (ML0091, ML0097, 
ML0620, ML1811, ML1812) secreted in E. coli as potential vaccines or diagnostic reagents 
for controlling leprosy. Because these ML proteins showed a relatively high amino acid 
identity with M. tuberculosis, they could be developed as vaccine candidates for both leprosy 
and tuberculosis.  ML secreted proteins could be delivered as DNA vaccines using a strong 
eukaryotic promoter. In addition, these ML secreted proteins could be used to improve BCG 
vaccines by creating new over-expressing recombinant BCG strains.  
These ML secreted proteins may not be good candidates for M. leprae-specific 
diagnostic reagents for leprosy because of the relatively high amino acid homology between 
the ML proteins and their M. tuberculosis homologs. However, it is possible that these 
secreted ML proteins and MT proteins have unique epitopes engendering immunological 
specificity for ML or MT.  
83 
Finally, some of the ML secreted proteins identified in this study have not been 
annotated and therefore, may have unique functional or structural capacities.  Further studies 
into their function and immunogenicity could lead to a fuller understanding of the host 
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